Document:

EX-10.14

 Exhibit 10.14 

EXECUTIVE EMPLOYMENT AGREEMENT 

This EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of this 2nd day of June 2019, by and between
Chewy, Inc., a Delaware corporation (the “Company”), and Mario Marte (“Executive”). 
 W I
T N E S S E T H : 
 WHEREAS, the Company desires to continue to employ Executive
and to enter into this Agreement embodying the terms of such employment, and Executive desires to enter into this Agreement and to be employed by the Company, subject to the terms and provisions of this Agreement. 

NOW, THEREFORE, in consideration of the promises and mutual covenants contained herein and for other good and valuable consideration, the
receipt and sufficiency of which are mutually acknowledged, the Company and Executive hereby agree as follows: 

Section 1.    Definitions. Capitalized terms not otherwise defined in this Agreement
shall have the meaning set forth on Appendix A, attached hereto. 

Section 2.    Acceptance and Term of Employment. 

The Company agrees to continue to employ Executive, and Executive agrees to continue to serve the Company, on the terms and conditions set
forth herein. The Term of Employment shall continue until terminated as provided in Section 7 hereof. 

Section 3.    Position, Duties, and Responsibilities; Place of Performance. 

(a)    Position, Duties, and Responsibilities. During the Term of Employment, Executive shall be employed and serve
as Chief Financial Officer and shall have such duties and responsibilities commensurate with such title. Executive will report to the Company’s Chief Executive Officer. 

(b)    Performance. Executive shall devote Executive’s full business time, attention, skill, and best efforts
to the performance of Executive’s duties under this Agreement and shall not engage in any other business or occupation during the Term of Employment, including, without limitation, any activity that (i) conflicts with the interests of the
Company or any other member of the Company Group, (ii) interferes with the proper and efficient performance of Executive’s duties for the Company or (iii) interferes with Executive’s exercise of judgment in the Company’s
best interests. Notwithstanding the foregoing, nothing herein shall preclude Executive from (i) serving, with the prior written consent of the Board, as a member of the boards of directors or advisory boards (or their equivalents in the case of
a non-corporate entity) of non-competing businesses and charitable organizations, (ii) engaging in charitable activities and community affairs, and
(iii) managing Executive’s personal investments and affairs; provided, however, that the activities set out in clauses (i), (ii), and (iii) shall be limited by Executive so as not to materially interfere,
individually or in the aggregate, with the performance of Executive’s duties and responsibilities hereunder. 

 Section 4.    Compensation. 

(a)    Base Salary. During the Term of Employment, Executive shall be paid an annualized Base Salary, payable in
accordance with the regular payroll practices of the Company, of $595,000, with increases, if any, as may be made by the Compensation Committee pursuant to the Company’s annual merit increase process. 

(b)    Bonus. With respect to each fiscal year ending during the Term of Employment, Executive shall be eligible to
earn an annual cash incentive bonus under any annual incentive program for senior executives established by the Board from time to time, if any (the “Bonus Plan”). Any such bonus opportunity may be based upon performance criteria
established by the Board or a committee thereof for such fiscal year (or other performance period) in consultation with Executive. The target amount for such annual cash incentive bonus shall be no less than 100% of Executive’s Base Salary (the
“Target Bonus”), and any actual bonus shall be determined in accordance with the terms of the annual cash incentive bonus plan as in effect from time to time (the “Bonus Plan”). Subject to the provisions of
Section 7, any bonus described in this Section 4(b) will be paid according and subject to the terms of the Bonus Plan under which it was awarded, and the Company shall not be required to adopt or continue to provide Executive with any
annual or other short-term cash incentive opportunity as a result of this Section 4(b). 
 (c)    Equity.
Executive shall be eligible to participate in any equity compensation plan or similar long-term incentive program adopted by the Company. The amount awarded to the Executive under any such plan, if any, shall be in the discretion of the Board or any
committee administering such plan. 
 Section 5.    Employee Benefits. During the Term
of Employment, Executive (and, with respect to health benefits, Executive’s eligible dependents) shall be entitled to immediately participate (without regard to any waiting period, except as required by applicable law) in health, insurance,
retirement, annual leave and time-off, and other benefits provided generally to similarly situated employees of the Company. Executive shall also be entitled to the same number of holidays, vacation days, and
sick days, as well as any other benefits, in each case as are generally allowed to similarly situated employees of the Company in accordance with the Company policy as in effect from time to time. Nothing contained herein shall be construed to limit
the Company’s ability to amend, suspend, or terminate any employee benefit plan or policy at any time without providing Executive notice, and the right to do so is expressly reserved. 

Section 6.    Reimbursement of Expenses. Executive is authorized to incur reasonable
business expenses in carrying out Executive’s duties and responsibilities under this Agreement, and the Company shall promptly reimburse Executive for all such reasonable business expenses, subject to documentation in accordance with the
Company’s policy, as in effect from time to time. 

  
 -2- 

 Section 7.    Termination of Employment. 

(a)    General. The Term of Employment shall terminate upon the earliest to occur of (i) Executive’s
death, (ii) a termination by reason of a Disability, (iii) a termination by the Company with or without Cause, and (iv) a termination by Executive for any reason. Upon any termination of Executive’s employment for any reason,
except as may otherwise be requested by the Company in writing and agreed upon in writing by Executive, Executive shall resign from any and all directorships, committee memberships, and any other positions Executive holds with the Company or any
other member of the Company Group. Notwithstanding anything herein to the contrary, the payment (or commencement of a series of payments) hereunder of any nonqualified deferred compensation (within the meaning of Section 409A of the Code) upon
a termination of employment shall be delayed until such time as Executive has also undergone a “separation from service” as defined in Treas. Reg. 1.409A-1(h), at which time such nonqualified
deferred compensation (calculated as of the date of Executive’s termination of employment hereunder) shall be paid (or commence to be paid) to Executive on the schedule set forth in this Section 7 as if Executive had undergone such
termination of employment (under the same circumstances) on the date of Executive’s ultimate “separation from service.” 

(b)    Termination Due to Death or Disability. Executive’s employment shall terminate automatically upon
Executive’s death. The Company may terminate Executive’s employment immediately upon the occurrence of a Disability, such termination to be effective upon Executive’s receipt of written notice of such termination. Upon
Executive’s death or in the event that Executive’s employment is terminated due to Disability, Executive or Executive’s estate or beneficiaries, as the case may be, shall be entitled to the Accrued Obligations. 

Following Executive’s death or a termination of Executive’s employment by reason of a Disability, except as set forth in this Section 7(b),
Executive shall have no further rights to any compensation or any other benefits under this Agreement. 

(c)    Termination by the Company for Cause. 

(i)    The Company may terminate Executive’s employment at any time for Cause, effective upon
Executive’s receipt of written notice of such termination; provided, however, that with respect to any Cause termination relying on clauses (i), (ii), (iv) or (v) of the definition of Cause, to the extent that such act or
acts or failure or failures to act are curable, Executive shall be given not less than ten (10) days’ written notice by the Board of the Company’s intention to terminate Executive for Cause, such notice to state in detail the
particular act or acts or failure or failures to act that constitute the grounds on which the proposed termination for Cause is based, and such termination shall be effective at the expiration of such ten (10) day notice period unless Executive
has fully cured such act or acts or failure or failures to act that give rise to Cause during such period. 

  
 -3- 

 (ii)    In the event that the Company terminates
Executive’s employment for Cause, Executive shall be entitled to the Accrued Obligations. Following such termination of Executive’s employment for Cause, except as required by law, or as set forth in this Section 7(c)(ii), Executive
shall have no further rights to any compensation or any other benefits under this Agreement. 
 (d)    Termination by
the Company without Cause Outside the Change in Control Period. The Company may terminate Executive’s employment at any time without Cause, effective upon Executive’s receipt of written notice of such termination. In the event that
Executive’s employment is terminated by the Company without Cause outside of the Change in Control Period, Executive shall be entitled to: 

(i)    The Accrued Obligations; 

(ii)    An amount equal to twelve (12) months of Executive’s Base Salary, payable in equal
monthly installments over the twelve (12) month period beginning on the first administratively practicable payroll following the effective date of the Release of Claims as set forth in Section 7(h) hereof, subject to such withholdings as
required by law; 
 (iii)    Payment of any annual bonus earned by Executive pursuant to
Section 4(b) for any fiscal year completed prior to the date of termination that remains unpaid as of the Date of Termination, payable at the same time as such annual bonuses are paid to executives generally for such year; 

(iv)    Payment of a pro-rated portion (based upon the number of
days that Executive was employed by the Company during the year of termination) of any annual bonus that would have been earned by Executive pursuant to a Bonus Plan adopted by the Company, if any, for the fiscal year in which such termination
occurred (based on actual performance during such year), which shall be payable at the same time as such annual bonuses are paid to executives generally for such year; and 

(v)    An amount equal to eighteen (18) multiplied by the total applicable monthly premium cost for
continued group health plan coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”), for Executive and Executive’s covered dependents under a group health plan sponsored by the Company in
which Executive (or such dependents) participated at the time of termination of employment (the “COBRA Severance”), payable in a lump sum payment within thirty (30) days following the date of termination based upon the premium
for the first month of COBRA. 

  
 -4- 

 (e)    Termination by the Company without Cause During the Change in
Control Period. In the event that Executive’s employment is terminated by the Company without Cause during the period beginning three (3) months prior to and ending twelve (12) months following the occurrence of a Change in
Control (the “Change in Control Period”), Executive shall be entitled to: 

(i)    amounts set forth in Section 7(d)(i), (ii), (iii) and (v); provided, however, that (x) the
number of months set forth in Section 7(d)(ii) shall be 18 and (y) all payments shall be paid in a lump sum payment within thirty (30) days following the date of termination (or, if later, within thirty (30) days following the
effectiveness of the Release of Claims), rather than in installments; and 
 (ii)    100% of Target Bonus
for the year of termination, paid in a lump sum payment within thirty (30) days following the date of termination, subject to such withholdings as required by law (or, if later, within thirty (30) days following the effectiveness of the
Release of Claims). 
 (f)    Non-Duplication of Payment
or Benefits: If (a) Executive’s termination occurs prior to a Change in Control that qualifies Executive for benefits under Section 7(d) of this Agreement and (b) a Change in Control occurs within the 3-month period following Executive’s termination that qualifies Executive for the superior benefits under Section 7(e) of this Agreement, then (i) Executive will cease receiving any
further payments or benefits under Section 7(d) of this Agreement and (ii) benefits payable under Section 7(e) of this agreement will be paid, offset by the corresponding amounts paid pursuant to 7(d). 

Notwithstanding the foregoing, the payments and benefits described above in Sections (except the Accrued Obligations) shall immediately
terminate, and the Company shall have no further obligations to Executive with respect thereto, in the event that Executive breaches any of the restrictive covenants contained in Schedule I attached hereto. For the avoidance of doubt, the
payments and benefits described above shall remain in effect even if Executive accepts other employment. Following such termination of Executive’s employment due to a termination without Cause, either outside or within a Change in Control
Period, except as required by law, or as set forth in this Section 7(d) or 7 (e), Executive shall have no further rights to any compensation or any other benefits under this Agreement 

(g)    Resignation by Executive. Executive may terminate Executive’s employment at any time . In the event of
a termination of employment by Executive under this Section 7(g), Executive shall be entitled only to the Accrued Obligations. In the event of termination of Executive’s employment under this Section 7(g), the Company may, in its sole
and absolute discretion, by written notice accelerate such date of termination. Following such termination of Executive’s employment by Executive, except as required by law, or as set forth in this Section 7(g), Executive shall have no
further rights to any compensation or any other benefits under this Agreement. 
 (h)    Release. Notwithstanding
any provision herein to the contrary, the payment of any amount or provision of any benefit pursuant to subsection (d) or (e) of this Section 7 (other than the Accrued Obligations) (collectively, the “Severance Benefits”)
shall be conditioned upon Executive’s execution, delivery to the Company, and non-revocation of the Release of Claims (and the expiration of any revocation period contained in such Release of Claims)
within sixty (60) days following the date of Executive’s termination of employment hereunder. If Executive fails to execute the Release of Claims in such a timely manner so as to permit any revocation period to expire prior to the end of
such sixty (60) day period, or timely 

  
 -5- 

 
revokes Executive’s acceptance of such release following its execution, Executive shall not be entitled to any of the Severance Benefits, provided that the Company must provide Executive
with the Release of Claims within five (5) business days following the date of Executive’s termination of employment hereunder. Further, to the extent that any of the Severance Benefits constitutes “nonqualified deferred
compensation” for purposes of Section 409A of the Code, any payment of any amount or provision of any benefit otherwise scheduled to occur prior to the sixtieth (60th) day following the
date of Executive’s termination of employment hereunder, but for the condition on executing the Release of Claims as set forth herein, shall not be made until the first regularly scheduled payroll date following such sixtieth (60th) day, after which any remaining Severance Benefits shall thereafter be provided to Executive according to the applicable schedule set forth herein. 

Section 8.    Certain Payments. 

(a)    Parachute Payments. Notwithstanding anything to the contrary herein, in the event that any payment or benefit
provided under this Agreement or any other plan, agreement or arrangement with the Company or any person affiliated with the Company (each a “Payment” and, collectively, the “Payments”) (i) constitutes
“parachute payments” within the meaning of Section 280G of the Code or any comparable successor provisions (“Section 280G”), and (ii) but for this Section 8 would be subject to the excise
tax imposed by Section 4999 of the Code or any comparable successor provisions (the “Excise Tax”), then the Executive’s Payments shall be either: 

(i)    Provided to the Executive in full, or 

(ii)    Provided to the Executive to such lesser extent would result in no portion being subject to the
Excise Tax, 
 whichever of the foregoing amounts, when taking into account applicable federal, state, local, and foreign income and employment taxes, the
Excise Tax, and any other applicable taxes, results in the receipt by the Executive, on an after-tax basis, of the greater amount, notwithstanding that all or some portion of the Payments may be taxable under
the Excise Tax. In the event that Section 8(a) applies and reduction is required to be applied to the Payments, the Payments shall be reduced by the Company in a manner and order of priority that provides the Executive with the largest net after-tax value; provided, that such other Payments of equal after-tax value shall be reduced in reverse order of payment. Notwithstanding anything to the contrary herein, any
reduction under this Section 8(a) shall be structured in a manner intended to comply with Section 409A of the Code. 

(b)    If requested by Executive, and provided that the Payments are eligible for the shareholder approval exemption under
Section 280G and the regulations thereunder and Executive contingently waives Executive’s rights to such Payments, the Company shall submit for approval by its stockholders, in conformance with Section 280G of the Code and the
regulations thereunder, any Payments that constitute “parachute payments” within the meaning of Section 280G of the Code or any comparable successor provisions. Upon such submission, Section 8(a) of this Agreement shall cease to
apply. 

  
 -6- 

 (c)    Determination by Professional Advisers. Any determinations
required under this Section 8 shall be made in writing in good faith by a professional service firm selected by the Company (the “Professional Advisers”). For purposes of making the calculations required by this Section 8,
the Professional Advisers may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application of the Code and other applicable legal authority. The Company
and the Executive shall furnish to the Professional Advisers such information and documents as the Professional Advisers may reasonably request in order to make a determination under this Section 8. The Company shall bear all costs the
Professional Advisers may reasonably incur in connection with any calculations contemplated by this Section 8; provided, that as required by Section 409A of the Code, the right to such benefit in kind is not subject to liquidation or
exchange for another benefit and the amount of such benefit in one year shall not affect any other benefits to be provided in any other year. 

(d)    Repayments and Reimbursements. If, notwithstanding any reduction in this Section 8, the Internal
Revenue Service (the “IRS”) determines that the Executive is liable for the Excise Tax as a result of the receipt of the Payments, then the Executive shall be obliged to pay back to the Company, within thirty (30) days after a
final IRS determination or in the event that the Executive challenges the final IRS determination, a final judicial determination, a portion of the Payments equal to “Repayment Amount.” The Repayment Amount shall be the smallest
such amount, if any, as shall be required to be paid to the Company so that the Executive’s net after-tax proceeds with respect to any Payment (after taking into account the Payment of the Excise Tax and
all other applicable taxes imposed on such Payment) shall be maximized. The Repayment Amount with respect to the Payment shall be zero if a Repayment Amount of more than zero would not result in the Executive’s net after-tax proceeds being maximized. If the Excise Tax is not eliminated pursuant to this paragraph, the Executive shall pay the Excise Tax. 

Notwithstanding any other provision of this Section 8, if (i) there is a reduction in the Payments under this Agreement as described in
Section 8(a), (ii) the IRS later determines that the Executive is liable for the Excise Tax, the payment of which would result in the maximization of the Executive’s net after-tax proceeds
(calculated as if the Executive’s Payments had not previously been reduced), and (iii) the Executive pays the Excise Tax, then the Company shall pay to the Executive the amount by which Executive’s Payments were reduced; provided,
that to the extent required by Section 409A of the Code, the reimbursement is made on or before the last day of the Executive’s taxable year following the taxable year in which the Excise Tax was paid; the right to reimbursement is not
subject to liquidation or exchange for another benefit; and the amount subject to reimbursement in one year shall not affect any other amounts eligible for reimbursement in any other year. 

If the Executive either (1) brings any action to enforce rights pursuant to this Section 8 or (2) defends any legal challenge to
Executive’s rights hereunder, the Executive shall be entitled to recover attorneys’ fees and costs incurred in connection with such action, regardless of the outcome of such action; provided that (i) if such action is commenced by the
Executive, the court finds the action was brought in good faith, (ii) the amounts eligible for reimbursement in one taxable year shall not affect the amount eligible for reimbursement in any other taxable year; (iii)

  
 -7- 

 
the reimbursement is made on or before the last day of the Executive’s taxable year following the taxable year in which the expense was incurred; and (iv) the right to reimbursement is
not subject to liquidation or exchange for another benefit. 
 Section 9.    Restrictive
Covenants. 
 Executive shall be bound by the restrictive covenants attached hereto as Schedule I. 

Section 10.    Representations and Warranties of Executive. 

Executive represents and warrants to the Company that in connection with Executive’s employment with the Company, Executive will not use
any confidential or proprietary information Executive may have obtained in connection with employment with any prior employer. 

Section 11.    Taxes. 

The Company may withhold from any payments made under this Agreement all applicable taxes, including but not limited to income, employment, and
social insurance taxes, as shall be required by law. Executive acknowledges and represents that the Company has not provided any tax advice to Executive in connection with this Agreement and that Executive has been advised by the Company to seek tax
advice from Executive’s own tax advisors regarding this Agreement and payments that may be made to Executive pursuant to this Agreement, including specifically, the application of the provisions of Section 409A of the Code to such
payments. 
 Section 12.    Set Off; Mitigation. 

The Company’s obligation to pay Executive the amounts provided and to make the arrangements provided hereunder shall be subject to set-off, counterclaim, or recoupment of amounts owed by Executive to the Company or its affiliates; provided, however, that to the extent any amount so subject to
set-off, counterclaim, or recoupment is payable in installments hereunder, such set-off, counterclaim, or recoupment shall not modify the applicable payment date of any
installment, and to the extent an obligation cannot be satisfied by reduction of a single installment payment, any portion not satisfied shall remain an outstanding obligation of Executive and shall be applied to the next installment only at such
time the installment is otherwise payable pursuant to the specified payment schedule. Executive shall not be required to mitigate the amount of any payment provided pursuant to this Agreement by seeking other employment or otherwise the amount of
any payment provided for pursuant to this Agreement shall not be reduced by any compensation earned as a result of Executive’s other employment or otherwise. 

  
 -8- 

 Section 13.    Additional
Section 409A Provisions. 
 Notwithstanding any provision in this Agreement to the contrary: 

(a)    Any payment otherwise required to be made hereunder to Executive at any date as a result of the termination of
Executive’s employment shall be delayed for such period of time as may be necessary to meet the requirements of Section 409A(a)(2)(B)(i) of the Code (the “Delay Period”). On the first business day following the expiration
of the Delay Period, Executive shall be paid, in a single cash lump sum, an amount equal to the aggregate amount of all payments delayed pursuant to the preceding sentence, and any remaining payments not so delayed shall continue to be paid pursuant
to the payment schedule set forth herein. 
 (b)    Each payment in a series of payments hereunder shall be deemed to be
a separate payment for purposes of Section 409A of the Code. 
 (c)    To the extent that any right to
reimbursement of expenses or payment of any benefit in-kind under this Agreement constitutes nonqualified deferred compensation (within the meaning of Section 409A of the Code), (i) any such expense
reimbursement shall be made by the Company no later than the last day of the taxable year following the taxable year in which such expense was incurred by Executive, (ii) the right to reimbursement or
in-kind benefits shall not be subject to liquidation or exchange for another benefit, and (iii) the amount of expenses eligible for reimbursement or in-kind
benefits provided during any taxable year shall not affect the expenses eligible for reimbursement or in-kind benefits to be provided in any other taxable year; provided, that the foregoing
clause shall not be violated with regard to expenses reimbursed under any arrangement covered by Section 105(b) of the Code solely because such expenses are subject to a limit related to the period the arrangement is in effect. 

(d)    While the payments and benefits provided hereunder are intended to be structured in a manner to avoid the
implication of any penalty taxes under Section 409A of the Code, in no event whatsoever shall any member of the Company Group be liable for any additional tax, interest, or penalties that may be imposed on Executive as a result of
Section 409A of the Code or any damages for failing to comply with Section 409A of the Code (other than for withholding obligations or other obligations applicable to employers, if any, under Section 409A of the Code). If any
provision of this Agreement (or of any award of compensation, including equity compensation or benefits) would cause Executive to incur any additional tax or interest under Section 409A of the Code, the Company shall, after consulting with and
receiving the approval of Executive, reform such provision in a manner intended to avoid the incurrence by Executive of any such additional tax or interest. 

Section 14.    Successors and Assigns; No Third-Party Beneficiaries. 

(a)    The Company. This Agreement shall inure to the benefit of the Company and its respective successors and
assigns. Neither this Agreement nor any of the rights, obligations, or interests arising hereunder may be assigned by the Company to a Person (other than another member of the Company Group, or its or their respective successors) without
Executive’s prior written consent (which shall not be unreasonably withheld, delayed, or conditioned); provided, however, that in the event of a sale of all or substantially all of the assets of the Company or any direct or
indirect division or subsidiary thereof to which Executive’s employment primarily relates, the Company may provide that this Agreement will be assigned to, and assumed by, the acquirer of such assets, division or subsidiary, as applicable,
without Executive’s consent. 

  
 -9- 

 (b)    Executive. Executive’s rights and obligations under
this Agreement shall not be transferable by Executive by assignment or otherwise, without the prior written consent of the Company; provided, however, that if Executive shall die, all amounts then payable to Executive hereunder shall
be paid in accordance with the terms of this Agreement to Executive’s devisee, legatee, or other designee, or if there be no such designee, to Executive’s estate. 

(c)    No Third-Party Beneficiaries. Except as otherwise set forth in Section 7(b) or Section 14(b)
hereof, nothing expressed or referred to in this Agreement will be construed to give any Person other than the Company, the other members of the Company Group, and Executive any legal or equitable right, remedy, or claim under or with respect to
this Agreement or any provision of this Agreement. 
 Section 15.    Waiver and
Amendments. 
 Any waiver, alteration, amendment, or modification of any of the terms of this Agreement shall be valid only if made in
writing and signed by each of the parties hereto; provided, however, that any such waiver, alteration, amendment, or modification must be consented to on the Company’s behalf by the Board. No waiver by either of the parties hereto
of their rights hereunder shall be deemed to constitute a waiver with respect to any subsequent occurrences or transactions hereunder unless such waiver specifically states that it is to be construed as a continuing waiver. 

Section 16.    Severability. 

If any covenant or other provisions of this Agreement are found to be invalid or unenforceable by a final determination of a court of competent
jurisdiction, (a) the remaining terms and provisions hereof shall be unimpaired, and (b) the invalid or unenforceable term or provision hereof shall be deemed replaced by a term or provision that is valid and enforceable and that comes
closest to expressing the intention of the invalid or unenforceable term or provision hereof. 

Section 17.    Governing Law; Waiver of Jury Trial. 

THIS AGREEMENT IS GOVERNED BY AND IS TO BE CONSTRUED UNDER THE LAWS OF THE STATE OF DELAWARE. EACH PARTY TO THIS AGREEMENT ALSO HEREBY WAIVES
ANY RIGHT TO TRIAL BY JURY IN CONNECTION WITH ANY SUIT, ACTION, OR PROCEEDING UNDER OR IN CONNECTION WITH THIS AGREEMENT. 

Section 18.    Notices. 

(a)    Place of Delivery. Every notice or other communication relating to this Agreement shall be in writing, and
shall be mailed to or delivered to the party for whom or which it is intended at such address as may from time to time be designated by it in a notice 

  
 -10- 

 
mailed or delivered to the other party as herein provided; provided, that unless and until some other address be so designated, all notices and communications by Executive to the Company
shall be mailed or delivered to the Company at its principal executive office, and all notices and communications by the Company to Executive may be given to Executive personally or may be mailed to Executive at Executive’s last known address,
as reflected in the Company’s records. 
 (b)    Date of Delivery. Any notice so addressed shall be deemed
to be given (i) if delivered by hand, on the date of such delivery, (ii) if mailed by courier or by overnight mail, on the first business day following the date of such mailing, and (iii) if mailed by registered or certified mail, on
the third business day after the date of such mailing. 
 Section 19.    Section Headings. 

The headings of the sections and subsections of this Agreement are inserted for convenience only and shall not be deemed to constitute a part
thereof or affect the meaning or interpretation of this Agreement or of any term or provision hereof. 

Section 20.    Entire Agreement. 

This Agreement, together with any exhibits attached hereto constitutes the entire understanding and agreement of the parties hereto regarding
the employment of Executive. This Agreement supersedes all prior negotiations, discussions, correspondence, communications, understandings, and agreements between the parties relating to the subject matter of this Agreement. 

Section 21.    Survival of Operative Sections. 

Upon any termination of Executive’s employment, the provisions of Section 7 through Section 22 of this Agreement (together with
any related definitions set forth in Appendix A hereof) shall survive to the extent necessary to give effect to the provisions thereof. 

Section 22.    Counterparts. 

This Agreement may be executed in two or more counterparts, each of which shall be deemed to be an original but all of which together shall
constitute one and the same instrument. The execution of this Agreement may be by actual or facsimile signature. 

*        *        * 

[Signatures to appear on the following page.] 

  
 -11- 

 IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date first above
written. 
  

			
	CHEWY, INC.
	
	     /s/ Sumit Singh

	By:	 	Sumit Singh
	Title:	 	Chief Executive Officer
	
	EXECUTIVE
	
	     /s/ Mario Marte

	Mario Marte

 APPENDIX A 

Definitions 

(a)    “Accrued Obligations” shall mean (i) all accrued but unpaid Base Salary through the date of
termination of Executive’s employment, (ii) any unpaid or unreimbursed expenses incurred in accordance with Section 6 hereof, (iii) Base Salary for any accrued vacation that Executive has not taken through the end of employment
and (iv) any benefits provided under the Company’s employee benefit plans upon a termination of employment, including rights with respect to Company equity (or equity derivatives), in accordance with the terms contained therein. 

(b)    “Agreement” shall have the meaning set forth in the preamble hereto. 

(c)    “Base Salary” shall mean the salary provided for in Section 4(a). 

(d)    “Board” shall have the meaning set forth in Section 3(a). 

(e)    “Cause” means a termination by the Company for one of the following reasons: (i) a refusal or
failure to follow the lawful and reasonable directions of the Board or individual to whom Executive reports, which refusal or failure is not cured within thirty (30) days following delivery of written notice of such conduct to Executive;
(ii) a material failure by the Executive to perform Executive’s duties in a manner reasonably satisfactory to the Company that is not cured within thirty (30) days following delivery of written notice of such failure to the Executive;
(iii) conviction of Executive of any felony involving fraud or act of dishonesty against the Company or any of its affiliates; (iv) conduct by Executive which, based upon good faith and reasonable factual investigation and determination of
the Company, demonstrates Gross Unfitness to serve; (v) intentional, material violation by Executive of any contractual, statutory, or fiduciary duty owed by Executive to the Company or any of its affiliates; or (vi) willful misconduct
that causes or is likely to cause material economic harm or public disgrace to the Company of any of its subsidiaries or affiliates. 

(f)     “Change in Control” shall have the definition set forth in the Company’s 2019
Omnibus Incentive Plan, as amended, modified, or supplemented from time to time. 
 (g)     “Code”
shall mean the Internal Revenue Code of 1986, as amended, and the rules and regulations promulgated thereunder. 

(h)    “Company” shall have the meaning set forth in the preamble hereto. 

(i)    “Company Group” shall mean the Company together with any of its direct or indirect subsidiaries.

 (j)    “Compensation Committee” shall mean the committee of the Board designated to make
compensation decisions relating to senior executive officers of the Company Group. Prior to any time that such a committee has been designated, the Board shall be deemed the Compensation Committee for purposes of this Agreement. 

(k)    “Delay Period” shall have the meaning set forth in Section 13 hereof. 

 (l)    “Disability” shall mean any physical or mental
disability or infirmity of Executive that has prevented the performance of Executive’s duties for a period of (i) ninety (90) consecutive days or (ii) one hundred twenty
(120) non-consecutive days during any twelve (12) month period; provided, however, that any leave of absence under the Family and Medical Leave Act or other medical leaves permitted by
the Company to other employees generally shall be excluded from this definition. Any question as to the existence, extent, or potentiality of Executive’s Disability upon which Executive and the Company cannot agree shall be determined by a
qualified, independent physician selected by the Company and approved by Executive (which approval shall not be unreasonably withheld). The determination of any such physician shall be final and conclusive for all purposes of this Agreement. 

(m)    “Executive” shall have the meaning set forth in the preamble hereto. 

(n)    “Gross Unfitness” shall mean engaging in gross negligence as to the performance of duties or
engaging in such severe conduct that Executive is no longer qualified to continue in Executive’s position. 

(o)     “Person” shall mean any individual, corporation, partnership, limited liability company, joint
venture, association, joint-stock company, trust (charitable or non-charitable), unincorporated organization, or other form of business entity. 

(p)    “Release of Claims” shall mean the Release of Claims in substantially the same form attached
hereto as Exhibit A (as the same may be revised from time to time by the Company upon the advice of counsel). 

(q)    “Severance Benefits” shall have the meaning set forth in Section 7(f) hereof. 

(r)    “Term of Employment” shall mean the period specified in Section 2 hereof. 

  
 -2- 

 Schedule I 

Restrictive Covenants 

1.    Non-Competition;
Non-Solicitation. Executive acknowledges and recognizes the highly competitive nature of the businesses of Chewy, Inc. (the “Company”) and its affiliates and accordingly agrees as follows:

 (b)    During Executive’s employment with the Company or its subsidiaries (the “Employment
Term”) and the Restricted Period, Executive will not, either directly, indirectly, or through others, solicit or attempt to solicit any employees, consultant, or independent contractor of the Company, subsidiaries, (collectively,
“Covered Persons”), to terminate his or her relationship with the Company or subsidiaries in order to become an employee, consultant, or independent contractor to or for any other person or entity; provided, that the foregoing shall
not be deemed to prohibit general media advertising or general employment solicitation not targeted towards Covered Persons. 

(c)    During the Restricted Period, Executive will not directly or indirectly compete with the Company anywhere within
the existing sales territory of the Company. The Company’s sales territory shall extend throughout any state in which the Company does business; or solicit any of the Company’s customers or prospective customers. 

For the purposes of this section, the term “Restricted Period” shall mean during Executive’s Employment Term and (x) for a period of
twelve (12) months thereafter if Executive’s employment is terminated by the Company for Cause or by the Executive for any reason or (y) for a period of eighteen (18) months thereafter if the Executive’s employment is
terminated by the Company without Cause. 
 (d)     As used in this Schedule I, to “Compete” shall mean
directly or indirectly to own, manage, operate, join, control, be employed by, or become a director, officer, shareholder (holding 5% or more of shares) of, or consultant to, any pet food, pet supplies, pet toys, pet supplements/drugs, pet retail
business or pet services business, including grooming salons or business that performs grooming services, pet training, pet boarding, or pet day-care, or any similar and related products or businesses. This
provision also applies to any e-commerce or direct mail business or service with at least (i) 50% of its products or services being pet-related or (ii) $50,000,000 in
annual pet-related product sales or services.  

(e)    It is expressly understood and agreed that although Executive and the Company consider the restrictions contained
in this Section 1 to be reasonable, if a final judicial determination is made by a court of competent jurisdiction that the time or territory or any other restriction contained in this Schedule I is an unenforceable restriction against
Executive, the provisions of this Schedule I shall not be rendered void but shall be deemed amended to apply as to such maximum time and territory and to such maximum extent as such court may judicially determine or indicate to be enforceable.
Alternatively, if any court of competent jurisdiction finds that any restriction contained in this Schedule I is unenforceable, and such restriction cannot be amended so as to make it enforceable, such finding shall not affect the enforceability of
any of the other restrictions contained herein. 

  
 -3- 

 (f)    The period of time during which the provisions of this
Section 1 shall be in effect shall be extended by the length of time during which Executive is in breach of the terms hereof as determined by any court of competent jurisdiction on the Company’s application for injunctive relief. 

(g)    The provisions of Section 1 hereof shall survive the termination of Executive’s employment for any
reason. 
 (h)    The provisions of Section 1 hereof shall not apply if Executive’s principal place of
employment on the date hereof is in the State of California. 
 2.     Confidentiality; Intellectual Property.

 (b)    Confidentiality. 

(i)    At all times during and after the Employment Term, Executive will hold in strictest confidence and
will not disclose to any unauthorized person or use (except in connection with Executive’s work for the Company and its Subsidiaries or otherwise for the benefit of the Company or its Subsidiaries) any Confidential Information of the Company.
“Confidential Information” means trade secrets and any information, process or idea considered confidential and not publicly disclosed by the Company that is acquired by Executive directly in connection with Executive’s work for the
Company and its Subsidiaries, and which, if disclosed, could reasonably cause non-de minimis harm to the Company and its Subsidiaries. Examples of Confidential Information may include: (i) the
Company’s customer and prospective customer lists (including, but not limited to, computer-based, rolodex, or address book information); (ii) the Company’s vendor and prospective vendor lists (including, but not limited to, computer based,
rolodex, or address book information); (iii) confidential correspondence, notes, files, memoranda, notebooks, drawings, schematics, specifications, plans, programs, price lists, inventory control lists, materials, data, information of any kind,
videotapes, tangible property, equipment, entry cards, identification badges and keys; (iv) confidential information regarding the Company’s operations, finances, methods, plans, and results; (v) the Company’s confidential
arrangements with suppliers and distributors; (vi) the Company’s confidential plans and strategies for research, development, expansion, store design, staffing and management systems, new products, purchasing, budgets, priorities,
marketing and sales; (vii) the Company’s confidential financial statements and data regarding sales, profits, productivity, purchasing arrangements, prices and costs; (viii) confidential information regarding the Company’s
computer systems and programs; (ix) third-party confidential information which the Company has a duty to maintain as confidential; (x) confidential personnel information such as the identities, capabilities, activities, compensation,
performance, and ratings of employees; (xi) confidential information regarding employee hiring, incentive, evaluation and discipline practices and programs; (xii) confidential training programs, techniques, and materials;
(xiii) confidential grooming methods and practices; (xiv) confidential marketing and promotional plans, methods, budgets and targets; and (xv) confidential cost-control methods and practices, in each case, that is acquired by
Executive directly in 

  
 -4- 

 
connection with Executive’s work for the Company and its Subsidiaries. Confidential Information does not include information that (x) was or becomes generally available to Executive on
a non-confidential basis, if the source of such information was not reasonably known to Executive to be bound by a duty of confidentiality; (y) was or becomes generally available to the public, other than
as a result of a disclosure by Executive; or (z) was independently developed by Executive without reference to Confidential Information. 

(ii)    Upon termination of Executive’s employment with the Company for any reason, Executive shall
deliver to the Company the originals and all copies of any and all notes, memoranda, records and documentation and any other material containing or disclosing any Confidential Information of the Company that are in Executive’s possession or
under Executive’s control. 
 (iii)    During the Employment Term, Executive shall not use or
disclose any confidential information or trade secrets, if any, of any former employer in violation of any continuing obligation to such employer. 

(iv)    Nothing in this Schedule I shall prohibit or impede the Executive from communicating, cooperating
or filing a complaint with any U.S. federal, state or local governmental or law enforcement branch, agency or entity (collectively, a “Governmental Entity”) with respect to possible violations of any U.S. federal, state or local law
or regulation, or otherwise making disclosures to any Governmental Entity, in each case, that are protected under the whistleblower provisions of any such law or regulation, provided that in each case such communications and disclosures are
consistent with applicable law. The Executive understands and acknowledges that an individual shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is made (i) in
confidence to a federal, state, or local government official or to an attorney solely for the purpose of reporting or investigating a suspected violation of law, or (ii) in a complaint or other document filed in a lawsuit or other proceeding,
if such filing is made under seal. The Executive understands and acknowledges further that an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the attorney of
the individual and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal; and does not disclose the trade secret, except pursuant to court order. Notwithstanding the
foregoing, under no circumstance will the Executive be authorized to disclose any information covered by attorney-client privilege or attorney work product of any member of the Company without prior written consent of the General Counsel or other
officer designated by the Company. 
 (c)    Intellectual Property. 

(i)    All work product including, but not limited to, deliverables, business continuity planning program,
designs, installation drawings, drawings, reports, calculations, maps, photographs, computer programs, code, software, development, 

  
 -5- 

 
systems design, specifications, notes, data, location lay-outs, services, and any other pertinent data, in whatever form of media, specifically prepared,
produced, created, and/or authored by Executive are works for hire (collectively referred to herein as “Work”) and are the exclusive property of the Company. To the extent title to any Work may not, by operation of law, vest in the
Company or the Work may not be considered works for hire, Executive irrevocably grants all Executive’s rights, title, and interest in the Work to the Company. The Company may obtain, and hold in its own name, copyrights, registrations, or such
other protections as may be appropriate to the subject matter of the Work. Upon the Company’s request, Executive agrees during and after the Employment Term to give the Company, at its expense, and any person designated by the Company,
reasonable assistance required to achieve or record these rights. (This paragraph, however, shall not be interpreted to require the assignment of any Work which Executive can prove Executive developed entirely on his or her own time, without the use
of any equipment, supplies, facilities or Confidential Information of the Company, and which neither results from the work Executive performs for the Company nor is related to the business of the Company). In the event that the Company is unable,
after reasonable effort, to secure Executive’s signature on any documents needed to apply for or prosecute a Work, Executive hereby irrevocably designates and appoints the Company and its duly authorized officers and agents as Executive’s
agent and attorney-in-fact, to act for and on Executive’s behalf to execute, verify and file any such applications and to do all other lawfully permitted acts to
further the prosecution and issuance of patents, copyrights, and other registrations available for protections with the same legal force and effect as if executed by Executive. Executive acknowledge that Executive is responsible for understanding,
complying with, an implementing the Company’s Intellectual Property Policy and Guidelines published by the Company as they apply to Executive’s position and area of accountability at the Company. 

3.    Non-Disparagement. 

Executive agrees that during the Employment Term, and at all times thereafter, Executive will not make any disparaging or defamatory comments regarding any
member of the Company, its affiliates and subsidiaries, or their respective current or former directors, officers, or employees in any respect or make any disparaging or defamatory comments concerning any aspect of Executive’s relationship with
any member of the Company, its affiliates and subsidiaries, or any comments concerning the conduct or events which precipitated any termination of Executive’s employment from any member of the Company, its affiliates and subsidiaries. The
Company shall instruct is directors, officers, and executives to not make any disparaging or defamatory comments regarding Executive. However, either party’s obligations under this Section 3 of Schedule I shall not apply to disclosures
required by applicable law, regulation, or order of a court or governmental agency. 

  
 -6- 

 Exhibit A 

RELEASE OF CLAIMS 

As used in this Release of Claims (this “Release”), the term “claims” will include all claims, covenants,
warranties, promises, undertakings, actions, suits, causes of action, obligations, debts, accounts, attorneys’ fees, judgments, losses, and liabilities, of whatsoever kind or nature, in law, in equity, or otherwise. 

For and in consideration of the Severance Benefits (as defined in my Employment Agreement, dated June 1, 2019, with Chewy, Inc. (the
“Employment Agreement”)), and other good and valuable consideration, I, Mario Marte, for and on behalf of myself and my heirs, administrators, executors, and assigns, effective the date on which this release becomes effective
pursuant to its terms, do fully and forever release, remise, and discharge each of the Company and each of its direct and indirect subsidiaries and affiliates, together with their respective officers, directors, partners, shareholders, employees,
and agents (collectively, the “Group”) from any and all claims whatsoever up to the date hereof that I had, may have had, or now have against the Group, for or by reason of any matter, cause, or thing whatsoever, including any claim
arising out of or attributable to my employment or the termination of my employment with the Company, whether for tort, breach of express or implied employment contract, intentional infliction of emotional distress, wrongful termination, unjust
dismissal, defamation, libel, or slander, or under any federal, state, or local law dealing with discrimination based on age, race, sex, national origin, handicap, religion, disability, or sexual orientation. This release of claims includes, but is
not limited to, all claims arising under the Age Discrimination in Employment Act (“ADEA”), Title VII of the Civil Rights Act, the Americans with Disabilities Act, the Civil Rights Act of 1991, the Family Medical Leave Act, and the
Equal Pay Act, each as may be amended from time to time, and all other federal, state, and local laws, the common law, and any other purported restriction on an employer’s right to terminate the employment of employees. The release contained
herein is intended to be a general release of any and all claims to the fullest extent permissible by law. 
 I acknowledge and agree that
as of the date I execute this Release, I have no knowledge of any facts or circumstances that give rise or could give rise to any claims under any of the laws listed in the preceding paragraph. 

By executing this Release, I specifically release all claims relating to my employment and its termination under ADEA, a United States federal
statute that, among other things, prohibits discrimination on the basis of age in employment and employee benefit plans. 
 Notwithstanding
any provision of this Release to the contrary, by executing this Release, I am not releasing (i) any claims relating to my rights under Section 7 of the Employment Agreement, (ii) any claims that cannot be waived by law, or
(iii) my right of indemnification as provided by, and in accordance with the terms of, applicable corporate law or the by-laws , certificate of incorporation or insurance policy providing such coverage of
any member of the Group, as any of such may be amended from time to time. 
 I expressly acknowledge and agree that I – 

 

	 	•	 	 Am able to read the language, and understand the meaning and effect, of this Release; 

	 	•	 	 Have no physical or mental impairment of any kind that has interfered with my ability to read and understand the
meaning of this Release or its terms, and that I am not acting under the influence of any medication, drug, or chemical of any type in entering into this Release; 

 

	 	•	 	 Am specifically agreeing to the terms of the release contained in this Release because the Company has agreed to
pay me the Severance Benefits in consideration for my agreement to accept it in full settlement of all possible claims I might have or ever had, and because of my execution of this Release; 

 

	 	•	 	 Acknowledge that, but for my execution of this Release, I would not be entitled to the Severance Benefits;

  

	 	•	 	 Understand that, by entering into this Release, I do not waive rights or claims under ADEA that may arise after
the date I execute this Release; 

  

	 	•	 	 Had or could have [twenty-one (21)][forty-five (45)]1 days from the date of my termination of employment (the “Release Expiration Date”) in which to review and consider this Release, and that if I execute this Release prior to the
Release Expiration Date, I have voluntarily and knowingly waived the remainder of the review period; 

  

	 	•	 	 Have not relied upon any representation or statement not set forth in this Release or my Employment Agreement
made by the Company or any of its representatives; 

  

	 	•	 	 Was advised to consult with my attorney regarding the terms and effect of this Release; and

  

	 	•	 	 Have signed this Release knowingly and voluntarily. 

I represent and warrant that I have not previously filed, and to the maximum extent permitted by law agree that I will not file, a complaint,
charge, or lawsuit against any member of the Group regarding any of the claims released herein. If, notwithstanding this representation and warranty, I have filed or file such a complaint, charge, or lawsuit, I agree that I shall cause such
complaint, charge, or lawsuit to be dismissed with prejudice and shall pay any and all costs required in obtaining dismissal of such complaint, charge, or lawsuit, including without limitation the attorneys’ fees of any member of the Group
against whom I have filed such a complaint, charge, or lawsuit. This paragraph shall not apply, however, to a claim of age discrimination under ADEA or to any non-waivable right to file a charge with the
United States Equal Employment Opportunity Commission (the “EEOC”); provided, however, that if the EEOC were to pursue any claims relating to my employment with Company, I agree that I shall not be entitled to recover
any monetary damages or any other remedies or benefits as a result and that this Release and the Severance Benefits will control as the exclusive remedy and full settlement of all such claims by me. 

 

	1 	 To be selected based on whether applicable termination was “in connection with an exit incentive or other
employment termination program” (as such phrase is defined in the Age Discrimination in Employment Act of 1967). 

  
 -2- 

 I hereby agree to waive any and all claims to
re-employment with the Company or any other member of the Company Group (as defined in my Employment Agreement) affirmatively agree not to seek further employment with the Company or any other member of the
Company Group. 
 Notwithstanding anything contained herein to the contrary, this Release will not become effective or enforceable prior to
the expiration of the period of seven (7) calendar days following the date of its execution by me (the “Revocation Period”), during which time I may revoke my acceptance of this Release by notifying the Company and the Board of
Directors of the Company, in writing, delivered to the Company at its principal executive office. To be effective, such revocation must be received by the Company no later than 11:59 p.m. on the seventh (7th) calendar day following the execution of this Release. Provided that the Release is executed and I do not revoke it during the Revocation Period, the eighth (8th) day following the date on which this Release is executed shall be its effective date. I acknowledge and agree that if I revoke this Release during the Revocation Period, this Release will be null
and void and of no effect, and neither the Company nor any other member of the Company will have any obligations to pay me the Severance Benefits. 

The provisions of this Release shall be binding upon my heirs, executors, administrators, legal personal representatives, and assigns. If any
provision of this Release shall be held by any court of competent jurisdiction to be illegal, void, or unenforceable, such provision shall be of no force or effect. The illegality or unenforceability of such provision, however, shall have no effect
upon and shall not impair the enforceability of any other provision of this Release. 
 EXCEPT WHERE PREEMPTED BY FEDERAL LAW, THIS RELEASE
SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH FEDERAL LAW AND THE LAWS OF THE STATE OF DELAWARE, APPLICABLE TO AGREEMENTS MADE AND TO BE PERFORMED IN THAT STATE WITHOUT GIVING EFFECT TO THE PRINCIPLES OF CONFLICTS OF LAWS. I HEREBY WAIVE ANY
RIGHT TO TRIAL BY JURY IN CONNECTION WITH ANY SUIT, ACTION, OR PROCEEDING UNDER OR IN CONNECTION WITH THIS RELEASE. 
 Capitalized terms
used, but not defined herein, shall have the meanings ascribed to such terms in my Employment Agreement. 
  

	
	  

	Mario Marte
	Date:

  

  
 -3-Exhibit 4.15

 

EXECUTION VERSION

 

 

 

SHARE SUBSCRIPTION AGREEMENT

 

by and between

 

ORIGIN AGRITECH LIMITED

 

and

 

LONG HAN INVESTMENT MANAGEMENT CO., LTD.

 

(隆瀚投资管理有限公司)

 

Dated as of October 16, 2018

 

 

 

     

     

    

 

TABLE OF CONTENTS

 

	ARTICLE I DEFINITIONS	1
	Section 1.01.	Defined Terms	1
	Section 1.02.	Interpretation and Rules of Construction	6
	ARTICLE II PURCHASE AND SALE	7
	Section 2.01.	Purchase and Sale	7
	Section 2.02.	Closing	7
	Section 2.03.	Closing Deliveries by the Company	8
	Section 2.04.	Closing Deliveries by the Investor	8
	ARTICLE III REPRESENTATIONS AND WARRANTIES OF THE COMPANY	8
	Section 3.01.	Organization and Qualification	8
	Section 3.02.	Corporate Authorization	9
	Section 3.03.	Valid Issuance of the Purchased Shares	9
	Section 3.04.	Capitalization	9
	Section 3.05.	Non-contravention	10
	Section 3.06.	Governmental Consents and Approvals	10
	Section 3.07.	No Actions	10
	Section 3.08.	Compliance with Law; Permits	10
	Section 3.09.	Subsidiaries	11
	Section 3.10.	SEC Reports	11
	Section 3.11.	Financial Statements	12
	Section 3.12.	Taxes	13
	Section 3.13.	Brokers	14
	Section 3.14.	No Additional Representations	14
	ARTICLE IV REPRESENTATIONS AND WARRANTIES OF THE INVESTOR	14
	Section 4.01.	Corporate Status	14
	Section 4.02.	Corporate Authorization	14
	Section 4.03.	Non-contravention	14
	Section 4.04.	Governmental Consents and Approvals	15
	Section 4.05.	Purchase for Own Account; Economic Risk	15
	Section 4.06.	Private Placement; Non-U.S. Person	15
	Section 4.07.	Brokers	16
	Section 4.08.	No Additional Representations	16
	ARTICLE V ADDITIONAL AGREEMENTS	16
	Section 5.01.	Further Assurance	16
	ARTICLE VI CONDITIONS TO CLOSING	16
	Section 6.01.	Conditions in connection with the Closing	16
	ARTICLE VII INDEMNIFICATION	17
	Section 7.01.	Survival of Representations and Warranties	17
	Section 7.02.	Indemnification	18
	Section 7.03.	Limits on Indemnification	18
	Section 7.04.	Third-Party Claims	19
	Section 7.05.	Exclusive Remedy	19

 

    i

     

    

 

	ARTICLE VIII TERMINATION	19
	Section 8.01.	Termination	19
	Section 8.02.	Effect of Termination	19
	ARTICLE IX MISCELLANEOUS	20
	Section 9.01.	Notices	20
	Section 9.02.	Public Announcements; Confidentiality	21
	Section 9.03.	Amendment	21
	Section 9.04.	Taxes and Expenses	21
	Section 9.05.	Assignment	22
	Section 9.06.	No Third-Party Beneficiaries	22
	Section 9.07.	Governing Law; Arbitration	22
	Section 9.08.	Entire Agreement	22
	Section 9.09.	Severability	23
	Section 9.10.	Counterparts	23
	Section 9.11.	Specific Performance	23
	 	 	 
	Exhibit	 	 
	Exhibit A	Form of Investor Rights Agreement	 

 

    ii

     

    

 

THIS SHARE SUBCRIPTION
AGREEMENT, dated as of October 16, 2018 (this “Agreement”), is by and between Origin Agritech Limited, a business
company incorporated under the laws of the British Virgin Islands (the “Company”), and Long Han Investment Management
Co., Ltd. (隆瀚投资管理有限公司), a company incorporated under the
laws of the People’s Republic of China (the “Investor”). The Company and the Investor are referred to
in this Agreement collectively as the “Parties” and individually as a “Party.”

 

RECITALS

 

WHEREAS, on the terms
and subject to the conditions set forth in this Agreement and pursuant to applicable Laws, the Company desires to issue and sell
to the Investor and the Investor desires to subscribe for and purchase from the Company, securities of the Company as set forth
in this Agreement; and

 

WHEREAS, the Company
has duly authorized and approved the execution and delivery of this Agreement and the Investor Rights Agreement and the consummation
of the transactions contemplated hereby and thereby (the “Transactions”).

 

NOW, THEREFORE, in consideration
of the mutual covenants and agreements contained in this Agreement, and for other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, and intending to be legally bound, the Parties to this Agreement hereby agree
as follows:

 

ARTICLE I

DEFINITIONS

 

Section 1.01. Defined
Terms. For the purposes of this Agreement, the following terms shall have the following meanings:

 

“Action”
means any claim, action, suit, arbitration, inquiry, litigation, proceeding or investigation by or before any Governmental Authority.

 

“Affiliate”
means, with respect to any specified Person, any other Person that controls, is controlled by, or is under common control with
such specified Person. As used herein, the term “control” (including the terms “controlled by”
and “under common control with”) means the possession, directly or indirectly, of the power to direct or to
cause the direction of the management and policies of a Person, whether through the ownership of voting securities, as trustee
or executor, by contract or otherwise.

 

“Agreement” shall have the meaning
ascribed to this term in the preamble to this Agreement.

 

“Bankruptcy
and Equity Exception” shall have the meaning ascribed to this term in Section 3.02.

 

“Board” means the Board of Directors
of the Company.

 

     

     

    

 

“Business
Day” means any day that is not a Saturday, a Sunday or other day on which commercial banks are required or authorized
by Law to be closed in the city of Beijing, Hong Kong or New York.

 

“Closing” shall have the meaning
ascribed to this term in Section 2.02.

 

“Closing Date” shall have the meaning
ascribed to this term in Section 2.02.

 

“Company”
shall have the meaning ascribed to this term in the preamble to this Agreement.

 

“Company
SEC Reports” shall have the meaning ascribed to this term in Section 3.10 (a).

 

“Contract”
means any legally binding contract, agreement, arrangement, note, bond, indenture, mortgage, indenture, lease, sublease, license,
permit, concession, franchise, plan or other instrument, right or obligation.

 

“Equity Purchase
Agreement” means the Equity Purchase Agreement, dated as of July 5, 2017, by and between the Company and L2 Capital,
LLC, including any amendment, renewal, replacement, or successor agreement and any future agreement that confers similar rights.

 

“Exchange
Act” means the United States Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

“Fundamental
Reps” means the representations and warranties of the Company contained in Section 3.01, Section 3.02, Section 3.03,
Section 3.04(a), and Section 3.05.

 

“GAAP”
means the generally accepted accounting principles as applied in the United States.

 

“Group” or “Group Companies”
means the Company and its Subsidiaries.

 

“Governmental
Authority” means any federal, national, foreign, supranational, state, provincial, local or other governmental, regulatory
or administrative authority, agency or commission or any court, tribunal, or judicial or arbitral body.

 

“Governmental
Order” means any order, writ, judgment, injunction, decree, stipulation, determination or award of any Governmental Authority.

 

“HKIAC” shall have the meaning ascribed
to this term in Section 9.08(b).

 

“HKIAC Rules” shall have the meaning
ascribed to this term in Section 9.08(b).

 

“Indemnified Party” shall have the
meaning ascribed to this term in Section 7.02.

 

“Injunction” shall have the meaning
ascribed to this term in Section 6.01(a).

 

    	 	2	 

     

    

 

“Intellectual
Property” means (a) inventions and discoveries, whether patentable or not, in any jurisdiction, including United States,
non-United States and international patents, patent applications (including divisions, continuations, continuations in part and
renewal applications) and statutory invention registrations, and any renewals, extensions or reissues thereof, in any jurisdiction
(b) trademarks, service marks, brand names, certification marks, trade dress, domain names, logos, trade names, corporate names
and other source identifiers, the goodwill associated with the foregoing and registrations and applications for registration thereof
including any extension, modification or renewal of any such registration or application, (c) copyrightable works, copyrights,
and registrations and applications for registration thereof, (d) confidential and proprietary information, including trade secrets
and know-how, (e) rights of privacy, publicity and endorsement, and (f) any similar intellectual property or proprietary rights.

 

“Investor”
shall have the meaning ascribed to this term in the preamble to this Agreement.

 

“Investor
Rights Agreement” means that certain Investor Rights Agreement to be entered into by and between the Company and the
Investor, substantially in the form attached hereto as Exhibit A.

 

“Knowledge”
means, with respect to the Company, the knowledge of the directors and senior executive officers of the Company after reasonable
inquiry.

 

“Law”
means any federal, national, foreign, supranational, state, provincial, local or similar statute, law, treaty, ordinance, regulation,
rule, code, order, requirement or rule of law (including common law) or any Governmental Order.

 

“Lien”
means any security interest, pledge, hypothecation, mortgage, lien, license, claim, charge, title retention, right to acquire,
option, levy, proxy, right of first refusal, and any other encumbrance or condition of any kind, including any restriction on the
use, voting, transfer, receipt of income or other exercise of any attributes of ownership.

 

“Losses”
means losses, damages, liabilities, deficiencies, Actions, judgments, interest, awards, penalties, fines, costs and expenses of
whatever kind, including reasonable attorneys’ fees and the cost of enforcing any right to indemnification hereunder; provided,
that “Losses” shall not include punitive damages, except in the case of fraud or to the extent actually awarded to
any Person by any Governmental Authority.

 

    	 	3	 

     

    

 

“Material
Adverse Effect” means any fact, event, circumstance, change, development or effect (any such item, an “Effect”)
that, individually or in the aggregate with all other Effects, has or would reasonably be expected to (a) have a material adverse
effect on the business, assets, financial condition or results of operations of the Group Companies, taken as a whole or (b) prevent
or materially delay the consummation of the Transactions by the Company or otherwise be materially adverse to the ability of the
Company to perform its obligations under this Agreement; provided, however, solely with respect to clause (a) above,
that in no event shall any Effect to the extent arising out of or resulting from any of the following, either alone or in combination,
constitute, or be taken into account in determining whether there has been a Material Adverse Effect: (i) changes in general business,
economic or political conditions or changes in financial, credit or securities markets in general; (ii) changes in GAAP or regulatory
or accounting requirements after the date hereof; (iii) changes in applicable Laws after the date hereof that are binding on any
Group Company; (iv) effects resulting from the consummation of the Transactions, or the public announcement of this Agreement or
the identity of the Parties, including any losses of customers or employees, or any disruption in or loss of suppliers, distributors,
providers or similar parties with whom any Group Company has any relationship, and the initiation of shareholder litigation or
other legal proceeding related to this Agreement or the Transactions; (v) acts of God, natural disasters, epidemics, declarations
of war, acts of sabotage or terrorism, or outbreak or escalation of hostilities; (vi) changes in the market price or trading volume
of the Shares (it being understood that the facts or occurrences giving rise to or contributing to such changes in this clause
(vi) may be taken into account in determining whether a Material Adverse Effect has occurred); (vii) actions or omissions of any
Group Company that are expressly required by this Agreement or with the written consent or at the written request of the Investor;
(viii) changes, effects or circumstances affecting the industries or markets in which any Group Company operates; or (ix) the failure
by any Group Company to meet any internal or industry estimates, expectations, forecasts, projections or budgets for any period
(it being understood that the facts or occurrences giving rise to or contributing to such failure may be taken into account in
determining whether a Material Adverse Effect has occurred); provided, that any Effects set forth in clauses (i), (ii),
(iii), (v) and (viii) above may be taken into account in determining whether a Material Adverse Effect has occurred if and to the
extent such Effects individually or in the aggregate have a materially disproportionate impact on the Group Companies, taken as
a whole, relative to the other participants in the industries in which the Group Companies conduct their businesses.

 

“NASDAQ” means The NASDAQ Stock
Market LLC.

 

“Organizational
Documents” means, with respect to an entity, its certificate of incorporation, articles of incorporation, by-laws, articles
of association, memorandum of association, certificate of trust, trust agreement, partnership agreement, limited partnership agreement,
certificate of formation, limited liability company agreement or operating agreement, as applicable.

 

“Party”
shall have the meaning ascribed to this term in the preamble to this Agreement.

 

“Permit”
means any permit, license, franchise, approval, registration, filing, qualification, variance, certificate, certification, consent
of any Governmental Authority.

 

    	 	4	 

     

    

 

“Permitted
Liens” means (a) statutory Liens for Taxes and other governmental charges and assessments not yet due or payable, (b)
Liens of carriers, warehousemen, mechanics, materialmen and other like Liens arising in the ordinary course of business, (c) easements,
rights of way, encroachments, zoning ordinances and other similar encumbrances affecting real property, (d) statutory Liens in
favor of lessors arising in connection with any leased property, and (e) Liens arising under securities or blue sky Laws.

 

“Person”
means any individual, partnership, firm, corporation, limited liability company, association, trust, unincorporated organization,
Governmental Authority or other entity.

 

“PRC”
means the People’s Republic of China, but solely for the purposes of this Agreement, excluding the Hong Kong Special Administrative
Region, the Macau Special Administrative Region and Taiwan.

 

“Preferred
Shares” means preferred shares of nil par value per share in the capital of the Company.

 

“Promissory
Note” means the Promissory Note, dated as of July 5, 2017, by and between the Company and L2 Capital, LLC, including
any amendment, renewal, replacement, or successor agreement and any future agreement that confers similar rights.

 

“Purchase Price” shall have the
meaning ascribed to this term in Section 2.01.

 

“Purchase
Price Per Share” shall have the meaning ascribed to this term in Section 2.01.

 

“Purchased Shares” shall have the
meaning ascribed to this term in Section 2.01.

 

“Record Date” shall have the meaning
ascribed to this term in Section 3.04(a).

 

“Representatives”
means, with respect to any Person, such Person’s Affiliates and such Person and its Affiliates’ respective directors,
officers, employees, members, partners, accountants, consultants, advisors, attorneys, agents and other representatives.

 

“SEC” means the United States Securities
and Exchange Commission.

 

“Securities
Act” means the United States Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

“Shares”
means ordinary shares of nil par value per share in the capital of the Company.

 

“Significant
Subsidiaries” means the Subsidiaries of the Company as defined in Article 1, Rule 1-02 of Regulation S-X under the Exchange
Act.

 

    	 	5	 

     

    

 

“Subsidiary”
of any Person means any corporation, partnership, joint venture or other legal entity: (a) of which voting power to elect a majority
of the board of directors or others performing similar functions with respect to such organization is held directly or indirectly
by such Person or by any one or more of such Person’s Subsidiaries, (b) of which at least fifty percent (50%) of the equity
interests is controlled by such Person or by any one or more of such Person’s Subsidiaries, (c) of which such Person or any
Subsidiary of such Person is a general partner, or (d) whose assets and financial results are consolidated with the net earnings
of such Person and are recorded on the books of such Person for financial reporting purposes in accordance with GAAP.

 

“Tax”
means (a) any federal, national, provincial, municipal, local or taxes, duties, imposts, levies, or other like assessments in the
nature of a tax, in each case, imposed by any Governmental Authority, including all net income (including enterprise income tax
and individual income withholding tax), turnover (including value-added tax, business tax, and consumption tax), resource (including
urban and township land use tax), special purpose (including land value-added tax, urban maintenance and construction tax, and
additional education fees), property (including urban real estate tax and land use fees), documentation (including stamp duty and
deed tax), filing, recording, tariffs (including import duty and import value-added tax), and other taxes, and (b) all interest,
penalties (administrative, civil or criminal), or additional amounts imposed by any Governmental Authority in connection with any
item described in clause (a) above.

 

“Tax Return”
means any report, return, document, declaration or other information or filing required to be supplied to any taxing authority
with respect to Taxes, including information returns or any documents with respect to or accompanying payments of estimated Taxes.

 

“Third-Party Claim” shall have the
meaning ascribed to this term in Section 7.04.

 

“Transactions”
shall have the meaning ascribed to this term in the recitals to this Agreement.

 

Section 1.02. Interpretation
and Rules of Construction . Whenever the words “include,” “includes” or “including” are
used in this Agreement, they shall be deemed to be followed by the words “without limitation.” The definitions contained
in this Agreement are applicable to the singular as well as the plural forms of such terms and to the masculine as well as to the
feminine and neuter genders of such term. When reference is made to an Article, Section, Schedule or Exhibit, such reference is
to an Article or Section of, or Schedule or Exhibit to, this Agreement unless otherwise indicated. References to clauses without
a cross-reference to a Section or subsection are references to clauses within the same Section or, if more specific, subsection.
References from or through any date shall mean, unless otherwise specified, from and including or through and including, respectively.
The table of contents and descriptive headings contained in this Agreement are included for convenience of reference only and shall
not affect in any way the meaning or interpretation of this Agreement. All terms defined in this Agreement shall have the defined
meanings when used in any certificate or other document made or delivered pursuant hereto, unless otherwise defined therein. The
words “hereof,” “herein” and “hereunder” and words of similar import, when used in this Agreement,
refer to this Agreement as a whole and not to any particular provision of this Agreement. Any references in this Agreement to “US$”
shall be to U.S. dollars. References to days mean calendar days unless otherwise specified. When used herein, the word “extent”
and the phrase “to the extent” shall mean the degree to which a subject or other thing extends, and such word or phrase
shall not simply mean “if.” The term “or” is not exclusive. The word “will” shall be construed
to have the same meaning and effect as the word “shall.” Any agreement, instrument or statute defined or referred to
herein or in any agreement or instrument that is referred to herein means such agreement, instrument or statute as from time to
time amended, modified or supplemented, including (in the case of agreements or instruments) by waiver or consent and (in the case
of statutes) by succession of comparable successor statutes, only to the extent the applicable amendment, modification or supplement
is also appropriately listed therein. References in this Agreement to specific laws or to specific provisions of laws shall include
all rules and regulations promulgated thereunder. Each of the Parties has participated in the drafting and negotiation of this
Agreement. If an ambiguity or question of intent or interpretation arises, this Agreement must be construed as if it is drafted
by all the parties and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of authorship
of any of the provisions of this Agreement.

 

    	 	6	 

     

    

 

ARTICLE II

PURCHASE AND SALE

 

Section 2.01. Purchase
and Sale. Upon the terms and subject to the conditions of this Agreement, at the Closing, the Company shall issue and sell
to the Investor, and the Investor shall subscribe for and purchase from the Company, 1,397,680 Shares (the “Purchased
Shares”), at a price per Share equal to US$5.54 (the “Purchase Price Per Share”). The aggregate purchase
price for all the Purchased Shares shall be US$7,743,147.20 (the “Purchase Price”). Each Purchased Share shall
be free and clear of all Liens (other than any applicable transfer or voting restrictions arising under applicable securities Laws
or the Investor Rights Agreement and any Liens under the Organizational Documents of the Company) and with all rights attaching
on and from the Closing.

 

Section 2.02. Closing.
Subject to the satisfaction or waiver of the conditions to the Closing set forth in Article VI, the closing of the purchase and
sale of the Purchased Shares (the “Closing”) shall take place remotely via the electronic exchange of the closing
documents and signatures by facsimile or email (in PDF format) at such other time and place as the Company and the Investor shall
mutually agree in writing, but in no event later than 60 Business Days after the date hereof (the date on which the Closing takes
place being the “Closing Date”). The Parties acknowledge and agree that all transactions occurring at the Closing
shall be deemed to be taken, and all documents to be executed and delivered by the Parties at the Closing shall be deemed to have
been executed and delivered, simultaneously at the Closing, and no proceedings shall be deemed taken nor any document executed
or delivered until all have been taken, executed and delivered.

 

    	 	7	 

     

    

 

Section 2.03.      Closing
Deliveries by the Company.

 

(a)       At
the Closing, the Company shall deliver or cause to be delivered to the Investor:

 

(i)       a
certified true copy of the Register of Members of the Company as of the Closing Date reflecting the Investor’s ownership
of the Purchased Shares and duly certified by the share registrar of the Company;

 

(ii)       a
copy of the resolutions duly and validly adopted by the Board evidencing its authorization and approval of the execution and delivery
of this Agreement and the Investor Rights Agreement and the consummation of the Transactions; and

 

(iii)       the
Investor Rights Agreement, duly executed by the Company.

 

(b)       The
Company shall deliver to the Investor a duly issued share certificate in the name of the Investor representing the Purchased
Shares as soon as practicable after the Closing but in no event later than ten (10) Business Days after the Closing.

 

Section 2.04.      Closing
Deliveries by the Investor.

 

(a)       At
the Closing, the Investor shall deliver or cause to be delivered to the Company:

 

(i)       the
Purchase Price by wire transfer of immediately available funds to the account specified by the Company; and 

 

(ii)       the
Investor Rights Agreement, duly executed by the Investor.

 

ARTICLE III

REPRESENTATIONS AND WARRANTIES OF THE COMPANY

 

Except as set forth
in the Company SEC Reports filed prior to the date of this Agreement (without giving effect to any amendment to any such Company
SEC Report filed on or after the date hereof and excluding any risk factor disclosures contained under the heading “Risk
Factors,” any disclosure of risks included in any “forward-looking statements” disclaimer or any other statements
that are similarly cautionary, predictive or forward-looking in nature), the Company hereby represents and warrants to the Investor,
as of the date hereof and as of the Closing Date, except if a representation or warranty is made as of a specified date, as of
such date, each of the representations and warranties contained in this Article III.

 

Section 3.01.      Organization
and Qualification. Each Group Company is a legal entity duly organized, validly existing and in good standing (to the extent
the relevant jurisdiction recognizes such concept of good standing) under the Laws of the jurisdiction of its organization. Each
Group Company has the requisite power and authority (corporate or otherwise) to own, lease or operate its properties and assets
and to carry on its business as it is now being conducted. Each Group Company is duly qualified to do business and is in good standing
(to the extent the relevant jurisdiction recognizes such concept of good standing) in each jurisdiction in which the nature of
the business conducted by it or the character of the properties and assets owned, leased or operated by it makes such qualification
necessary, except where the failure to be so qualified or in good standing would not, individually or in the aggregate, have a
Material Adverse Effect.

 

    	 	8	 

     

    

 

Section 3.02.      Corporate
Authorization. The Company has all necessary corporate power and authority to execute and deliver this Agreement and the Investor
Rights Agreement and to perform its obligations hereunder and thereunder. The execution, delivery and performance of this Agreement
and Investor Rights Agreement by the Company have been duly authorized by all necessary corporate action on the part of the Company.
This Agreement has been, and the Investor Rights Agreement will be, duly executed and delivered by the Company, and when executed
and delivered by the Company, assuming due authorization, execution and delivery by the other parties thereto, constitutes a legal,
valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except as enforcement
may be limited by general principles of equity, whether applied in a court of Law or a court of equity, and by applicable bankruptcy,
insolvency and similar Law affecting creditors’ rights and remedies generally (the “Bankruptcy and Equity Exception”).

 

Section 3.03.      Valid
Issuance of the Purchased Shares. The Purchased Shares, when issued in accordance with the terms and conditions of this Agreement
and sold against receipt of consideration therefor, will be validly issued, fully paid and nonassessable, free and clear of any
and all Liens (other than any applicable transfer or voting restrictions arising under applicable securities Laws or the Investor
Rights Agreement).

 

Section 3.04.      Capitalization.

 

(a)       The
Company is authorized to issue (i) 60,000,000 Shares, of which approximately 3,261,253 Shares are issued and outstanding as of
August 1, 2018 (the “Record Date”) and (ii) 10,000,000 Preferred Shares, of which none are issued and outstanding
as of the Record Date. As of the Record Date, the Company has also granted approximately 685,174 outstanding options to purchase
Shares under the equity incentive plans of the Company and there are Shares issued and held in the treasury of the Company. All
of the issued and outstanding shares of the Company have been duly authorized and validly issued and are fully paid and nonassessable.

 

(b)       Except
as set forth in ‎Section 3.04(a) and the Shares reserved for issuance under the
equity incentive plans of the Company, the Equity Purchase Agreement, the Promissory Note and the proposed issuance of the Purchased
Shares pursuant to the terms herein, there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments
of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for,
or giving any Person any right to subscribe for or acquire any Shares, or contracts, commitments, understandings or arrangements
by which any Group Company is or may become bound to issue additional Shares.

 

    	 	9	 

     

    

 

Section 3.05.      Non-contravention.
The execution, delivery and performance by the Company of this Agreement and the Investor Rights Agreement do not and will not
(a) violate any provision of the Organizational Documents of the Company, (b) violate any Law or Governmental Order applicable
to any Group Company or (c) conflict with, result in any breach of, constitute a default (or an event which with the giving of
notice or lapse of time, or both, would become a default) under, require any consent under, or give to others any rights of termination,
amendment, acceleration, suspension, revocation or cancellation of, any Contract to which any Group Company is a party or result
in the creation of any Lien upon any of the properties or assets of any Group Company, other than, in the case of clauses (b) and
(c) above, any such conflict, violation, default, termination, amendment, acceleration, suspension, revocation or cancellation
that would not have, individually or in the aggregate, a Material Adverse Effect.

 

Section 3.06.      Governmental
Consents and Approvals. The execution, delivery and performance by the Company of this Agreement and the Investor Rights Agreement
do not and will not require any consent, approval, authorization or other order of, action by, filing with, or notification to,
any Governmental Authority, other than any approvals or filings required in connection with or in compliance with any obligations
under the Securities Act, the Exchange Act and the rules and regulations of the NASDAQ, except, in each case, where failure to
obtain such consent, approval, authorization or action, or to make such filing or notification would not, individually or in the
aggregate, result in a Material Adverse Effect.

 

Section 3.07.      No
Actions. There are no Actions against any of the Group Companies pending or, to the Knowledge of the Company, threatened before
any Governmental Authority which would, individually or in the aggregate, result in a Material Adverse Effect.

 

Section 3.08.      Compliance
with Law; Permits.

 

(a)       Except
as would not, individually or in the aggregate, have a Material Adverse Effect, the Group Companies are, and since January 1, 2013
(or the date of its formation, if later) has been in compliance with all Laws and Governmental Orders applicable to them. The Group
Companies hold all material Permits necessary for the lawful conduct of their respective businesses and are in compliance in all
material respects with the terms of all such Permits.

 

(b)       None
of the Group Companies or any of their respective directors, executives or, to the Knowledge of the Company, agents has, in any
material respect, (i) used any corporate funds for any illegal contributions, gifts, entertainment or other unlawful expenses relating
to political activity, (ii) used any corporate funds for any direct or indirect unlawful payments to any foreign or domestic government
officials or employees, (iii) violated or is violating any provision of the U.S. Foreign Corrupt Practices Act of 1977, the PRC
Law on Anti-Unfair Competition promulgated on September 2, 1993, or the Interim Rules on Prevention of Commercial Bribery promulgated
on November 15, 1996, or any PRC Law in relation thereto, (iv) established or maintained any fund of corporate monies or other
properties not recorded on the books and records of any Group Company, (v) to the Knowledge of the Company, made any bribe, unlawful
rebate, payoff, influence payment, kickback or other unlawful payment of any nature, or (vi) violated or operated in noncompliance
with any applicable money laundering law, anti-terrorism law or regulation, anti-boycott regulations, export restrictions or embargo
regulations. None of the Group Companies or any of their respective directors, executives or, to the Knowledge of the Company,
agents is currently the target of any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury
Department.

 

    	 	10	 

     

    

 

Section 3.09.      Subsidiaries.

 

(a)       All
of the outstanding shares of capital stock or voting securities of, or other ownership interests in each Significant Subsidiary
have been duly authorized and validly issued, fully paid and nonassessable and are owned beneficially and of record by the Company
or one of its Subsidiaries as set forth in in the Company SEC Reports, free and clear of any Liens.

 

(b)       There
are no issued, reserved for issuance or outstanding (i) shares of capital stock or voting securities of, or other ownership interests
in any Significant Subsidiary, (ii) no outstanding securities of the Company or any Significant Subsidiary convertible or exchangeable
for shares of capital stock or voting securities of, or other ownership interests in any Significant Subsidiary and (iii) rights,
options, warrants, calls or other similar rights, agreements or commitments that obligate the Company or any Significant Subsidiary
to (A) issue, transfer or sell any shares of capital stock or voting securities of, or other ownership interests in any Significant
Subsidiary or any securities convertible into or exchangeable for such shares of capital stock, voting securities or other ownership
interests, (B) give any person a right to subscribe for or acquire any shares of capital stock or voting securities of, or other
ownership interests in any Significant Subsidiary or (C) redeem or otherwise acquire any shares of capital stock or voting securities
of, or other ownership interests in any Significant Subsidiary.

 

Section 3.10.      SEC
Reports.

 

(a)       The
Company has timely filed or furnished, as the case may be, all registration statements, proxy statements, reports, forms and other
documents required to be filed or furnished by it with the with the SEC (all of the foregoing documents filed with or furnished
to the SEC and all exhibits included therein are referred to as the “Company SEC Reports”) for the one (1) year
preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material). As of
their respective effective dates (in the case of the Company SEC Reports that are registration statements filed pursuant to the
requirements of the Securities Act) and as of their respective filing dates (in the case of all other Company SEC Reports), or
in each case, if amended prior to the date hereof, as of the date of the last such amendment, (i) each Company SEC Report complied
in all material respects with the applicable requirements of the Securities Act or the Exchange Act, and (ii) none of such Company
SEC Reports contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein
or necessary in order to make such statements made therein, in the light of the circumstances under which they were made, not misleading.

 

    	 	11	 

     

    

 

(b)       The
Company has established and maintains disclosure controls and procedures (as defined in Rule 13a-15 under the Exchange Act). Such
disclosure controls and procedures are designed to ensure that material information relating to the Company, including its Subsidiaries,
is made known to Company’s principal executive officer and principal financial officer by others within those entities, particularly
during the periods in which the periodic reports required under the Exchange Act are being prepared. Such disclosure controls and
procedures are effective in timely alerting the Company principal executive officer and principal financial officer to material
information required to be included in the Company’s periodic and current reports required under the Exchange Act. For purposes
of this Agreement, “principal executive officer” and “principal financial officer” shall have the meanings
given to such terms in the Sarbanes-Oxley Act of 2002. The Company is in compliance in all material respects with the provisions
of the Sarbanes-Oxley Act of 2002 that are applicable to the Company.

 

(c)       The
Company is in compliance in all material respects with the applicable listing and corporate governance rules and regulations of
NASDAQ, and has not, in the twelve (12) months preceding the date hereof, received notice from NASDAQ to the effect that the Company
is not in compliance with such listing and corporate governance rules and regulations.

 

Section 3.11.      Financial
Statements.

 

(a)       Each
of the consolidated financial statements (including any related notes) contained or incorporated in the Company SEC Reports: (a)
was prepared in accordance with GAAP applied on a consistent basis throughout the period indicated therein (except as may be indicated
in such financial statements or the notes thereto and except that the unaudited financial statements may not contain all footnotes
required by GAAP), and (b) fairly present in all material respects the consolidated financial position of the Company and its consolidated
Subsidiaries as of the respective dates thereof and the consolidated results of operations, cash flows and changes in shareholders’
equity of the Company and its consolidated Subsidiaries for the respective periods covered thereby in accordance with GAAP (subject,
in the case of any unaudited financial statements, to normal year-end audit adjustments). No Group Company has any liabilities
or obligations of any nature (absolute, accrued, contingent or otherwise), except for liabilities or obligations (i) reflected
or reserved for in the consolidated balance sheet as of June 30, 2018 that is included in the Company SEC Reports, (ii) incurred
after June 30, 2018 in the ordinary course of business consistent with past practice, and (iii) that would not, individually or
in the aggregate, have a Material Adverse Effect.

 

    	 	12	 

     

    

 

(b)       The
Company and its Subsidiaries have established and maintained a system of internal controls over financial reporting (as defined
in Rule 13a-15 under the Exchange Act) sufficient to provide reasonable assurance regarding the reliability of the Company’s
financial reporting and the preparation of Company financial statements for external purposes in accordance with GAAP. The Company
has disclosed, based on its most recent evaluation of internal controls prior to the date hereof, to the Company’s auditors
and audit committee (i) any significant deficiencies and material weaknesses in the design or operation of internal controls which
are reasonably likely to adversely affect the Company’s ability to record, process, summarize and report financial information
and (ii) any fraud, whether or not material, that involves management or other employees who have a significant role in internal
controls.

 

Section 3.12.     Taxes.
All material Tax Returns of the Group Companies have been timely filed in accordance with applicable Laws and all such Tax Returns
are true, correct, and complete in all material respects. All material Taxes (whether or not shown on a Tax Return) of the Group
Companies have been timely paid. Each of the Group Companies has timely paid or withheld all material Taxes required to be paid
or withheld with respect to its employees, independent contractors, creditors and other third parties and timely paid over such
Taxes to the appropriate Governmental Authority. None of the Group Companies has executed any outstanding waiver of any statute
of limitations or outstanding extension of the period, for the assessment or collection of any material Tax. To the Knowledge of
the Company, no audit or Action of, or with respect to, any material Tax Return or material Taxes of any Group Company is currently
in progress or threatened. No deficiency for any material amount of Tax has been asserted or assessed by a Governmental Authority
against the Group Companies that has not been satisfied by payment, settled or withdrawn. All preferential tax treatments granted
to the Group Companies have been properly approved by or filed with the competent Governmental Authorities in accordance with applicable
Laws. No written claim has been made by a Governmental Authority in any jurisdiction where any Group Company has not filed Tax
Return that such Person is or may be subject to Tax or any filing requirement related to Tax in that jurisdiction. None of the
Group Companies is a party to or bound by, or has any obligation under, any Tax allocation agreement, Tax indemnity agreement,
Tax sharing agreement or similar contract or arrangement to indemnify any other Person with respect to Taxes that will be in effect
after the Closing. The charges, accruals and reserves for Taxes with respect to the Group Companies reflected on the books and
records of the Group Companies are adequate to cover material Tax liabilities accruing through the end of the last period for which
the Group Companies ordinarily record items on their respective books. Since the end of the last period for which the Group Companies
ordinarily record items on their respective books, none of the Group Companies has engaged in any transaction, or taken any action
that would materially impact any Tax asset or Tax liability of the Group Companies.

 

    	 	13	 

     

    

 

Section 3.13.      Brokers.
No broker, finder or investment banker is entitled to any brokerage, finder’s or other fee or commission in connection with
the transactions contemplated by this Agreement based upon arrangements made by or on behalf of the Company or any of its Subsidiaries.

 

Section 3.14.      No
Additional Representations. The Company acknowledges that the Investor makes no express or implied representations or warranties
as to any matter whatsoever except as expressly set forth in this Agreement, the Investor Rights Agreement or any certificate delivered
by the Investor to the Company in accordance with the terms hereof and thereof, and that any such other representations and warranties
are expressly disclaimed and that the Company does not rely on any such other representations and warranties or the accuracy or
completeness thereof.

 

ARTICLE IV

REPRESENTATIONS AND WARRANTIES OF THE INVESTOR

 

The Investor represents
and warrants to the Company, as of the date hereof and as of the Closing Date, except if a representation or warranty is made as
of a specified date, as of such date, each of the representations and warranties contained in this Article IV.

 

Section 4.01.      Corporate
Status. The Investor is a legal entity duly organized, validly existing and in good standing under the Laws of the jurisdiction
of its organization. The Investor has the requisite power and authority (corporate or otherwise) to own, lease or operate its properties
and assets and to carry on its business as it is now being conducted. The Investor is duly qualified to do business and is in good
standing (to the extent the relevant jurisdiction recognizes such concept of good standing) in each jurisdiction in which the nature
of the business conducted by it or the character the properties and assets owned, leased or operated by it makes such qualification
necessary in each case in all material respects.

 

Section 4.02.     Corporate
Authorization. The Investor has all necessary corporate power and authority to execute and deliver this Agreement and the
Investor Rights Agreement and to perform its obligations hereunder and thereunder. The execution, delivery and performance of
this Agreement and Investor Rights Agreement by the Investor have been duly authorized by all necessary corporate action on the
part of the Investor. This Agreement has been, and the Investor Rights Agreement will be, duly executed and delivered by the Investor,
and when executed and delivered by the Investor, assuming due authorization, execution and delivery by the other parties thereto,
constitutes a legal, valid and binding obligation of the Investor, enforceable against the Investor in accordance with its terms,
subject to the Bankruptcy and Equity Exception.

 

Section 4.03.      Non-contravention.
The execution, delivery and performance by the Investor of this Agreement and the Investor Rights Agreement do not and will not
(a) violate any provision of the Organizational Documents of the Investor, (b) violate any Law or Governmental Order applicable
to the Investor or (c) conflict with, result in any breach of, constitute a default (or an event which with the giving of notice
or lapse of time, or both, would become a default) under, require any consent under, or give to others any rights of termination,
amendment, acceleration, suspension, revocation or cancellation of, any Contract to which the Investor is a party or result in
the creation of any Lien upon any of the properties or assets of the Investor, other than in the case of clauses (b) and (c) above,
any such violation, conflict, breach, default, termination, amendment, acceleration, suspension, revocation or cancellation that
would not, individually or in the aggregate, prevent or materially delay the performance of the Investor’s obligations under
this Agreement.

 

    	 	14	 

     

    

 

Section 4.04.      Governmental
Consents and Approvals. The execution, delivery and performance by the Investor of this Agreement and the Investor Rights Agreement
do not and will not require any consent, approval, authorization or other order of, action by, filing with, or notification to,
any Governmental Authority, other than any approvals or filings required in connection with or in compliance with any obligations
under the Securities Act and the Exchange Act, except where in each case, the failure to obtain such consent, approval, authorization,
action or to make such filing or notification would not, individually or in the aggregate, prevent or materially delay the performance
of the Investor’s obligations under this Agreement.

 

Section 4.05.     Purchase
for Own Account; Economic Risk. The Investor is acquiring its Purchased Shares for investment for its own account and not with
a view to the distribution thereof in violation of the Securities Act. The Investor acknowledges that it (a) can bear the economic
risk of its investment in the Purchased Shares, and (b) has such knowledge and experience in financial or business matters that
it is capable of evaluating the merits and risks of the investment in the Purchased Shares.

 

Section 4.06.     Private
Placement; Non-U.S. Person. The Investor understands that (a) the Purchased Shares have not been registered under the Securities
Act or any state securities Laws and (b) the Purchased Shares may not be sold unless such disposition is registered under the Securities
Act and applicable state securities Laws or is exempt from registration thereunder. The Investor represents that it is not a U.S.
Person and it is located outside the United States, as such terms are defined in Rule 902 of Regulation S under the Securities
Act. The Investor acknowledges that the certificates representing the Purchased Shares will bear the following legend:

 

“THE SECURITIES EVIDENCED
HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), AND MAY NOT BE TRANSFERRED
EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION UNDER THE ACT OR IN A TRANSACTION WHICH, IN THE OPINION OF COUNSEL REASONABLY SATISFACTORY
TO THE COMPANY, QUALIFIES AS AN EXEMPT TRANSACTION UNDER THE ACT AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER. THE SECURITIES
ARE SUBJECT TO THE TRANSFER RESTRICTIONS SET FORTH IN AN INVESTOR RIGHTS AGREEMENT BY AND BETWEEN THE SHAREHOLDER AND THE COMPANY.”

 

    	 	15	 

     

    

 

Section 4.07.      Brokers.
No broker, finder or investment banker is entitled to any brokerage, finder’s or other fee or commission in connection with
the transactions contemplated by this Agreement based upon arrangements made by or on behalf of the Investor.

 

Section 4.08.      No
Additional Representations. The Investor acknowledges that the Company makes no express or implied representations or warranties
as to any matter whatsoever except as expressly set forth in this Agreement, the Investor Rights Agreement or any certificate delivered
by the Company to the Investor in accordance with the terms hereof and thereof, and that any such other representations and warranties
are expressly disclaimed and that the Investor does not rely on any such other representations and warranties or the accuracy or
completeness thereof.

 

ARTICLE V

ADDITIONAL AGREEMENTS

 

Section 5.01.      Further
Assurance. During the period from the execution of this Agreement to the Closing, each of the Parties agrees to do or cause
to be done all things necessary or reasonably advisable under applicable Laws to consummate the Transactions on a timely basis,
including using its commercially reasonable efforts to give such notices and obtain all other authorizations, consents, orders
and approval of all Governmental Authorities and other third parties that may be or become necessary for its execution and delivery
of, and the performance of its obligations pursuant to, this Agreement.

 

ARTICLE VI

CONDITIONS TO CLOSING

 

Section 6.01.      Conditions
in connection with the Closing.

 

(a)       Condition to Obligations of Each Party. The obligations of each Party to consummate the Transactions shall be subject to
the satisfaction or waiver (where permissible), at or prior to the Closing, of the following condition: No Governmental
Authority shall have enacted, issued, promulgated, enforced or entered any Law which is then in effect (whether temporary,
preliminary or permanent) and has the effect of enjoining, restraining, prohibiting or otherwise making the consummation of
the Transactions illegal (an “Injunction”).

 

(b)       Conditions
to Obligations of the Company. The obligations of the Company to consummate sale and purchase of the Purchased Shares shall
be subject to the satisfaction or waiver (where permissible), at or prior to the Closing, of each of the following conditions:

 

(i)       The
representations and warranties of the Investor contained in Article IV of this Agreement (i) that are qualified by materiality
shall be true and correct in all respects, and (ii) that are not qualified by materiality, shall be true and correct in material
respects, in each case of (i) and (ii), as of the date of this Agreement and as of the Closing (except for representations and
warranties that expressly speak as of a specified date, in which case as of such specified date).

 

    	 	16	 

     

    

 

(ii)       The
Investor shall have performed and complied in all material respects with all agreements, covenants and conditions contained in
this Agreement that are required to be performed or complied with by them at or prior to the Closing.

 

(c)       Conditions
to Obligations of the Investor. The obligations of the Investor to consummate the sale and purchase of the Purchased Shares
shall be subject to the satisfaction or waiver (where permissible), at or prior to the Closing, of each of the following conditions:

 

(i)       The
representations and warranties of the Company contained in Article III (i) that are qualified by materiality or Material Adverse
Effect, shall be true and correct in all respects, and (ii) that are not qualified by materiality or Material Adverse Effect, shall
be true and correct in material respects, in each case of (i) and (ii), as of the date of this Agreement and as of the Closing
(except for representations and warranties that expressly speak as of a specified date, in which case as of such specified date).

 

(ii)       The
Company shall have performed and complied in all material respects with all agreements, covenants and conditions contained in this
Agreement that are required to be performed or complied with by it at or prior to the Closing.

 

(iii)       No
stop order or suspension of trading shall have been imposed by NASDAQ, the SEC or any other Governmental Authority with respect
to public trading in the Shares.

 

ARTICLE VII

INDEMNIFICATION

 

Section 7.01.      Survival
of Representations and Warranties.

 

(a)       The
representations and warranties of the Company contained in this Agreement shall survive the Closing until one (1) year after the
Closing; provided, however, that the Fundamental Reps shall survive indefinitely. The covenants and agreements of
the Company set forth in this Agreement shall survive the Closing until fully discharged in accordance with their terms. The Investor’
right to indemnification with respect to the representations, warranties, covenants or agreements of the Company shall not be affected
or deemed waived by reason of any investigation made at any time by or on behalf of the Investor.

 

(b)       Notwithstanding
the foregoing, any claims asserted in good faith with reasonable specificity (to the extent known at such time) and in writing
by notice from the Investor to the Company prior to the expiration date of the applicable survival period shall not thereafter
be barred by the expiration of the relevant representation, warranty, covenant or agreement and such claims shall survive until
finally resolved.

 

    	 	17	 

     

    

 

Section 7.02.      Indemnification.
Following the Closing, the Company shall indemnify and defend the Investor and its Representatives (each an “Indemnified
Party”) against, and shall hold each of them harmless from and against, any and all Losses actually suffered or incurred
by, or imposed upon, the Indemnified Parties arising out of or resulting from:

 

(a)       any
inaccuracy or breach of any representation or warranty made by the Company under this Agreement; or

 

(b)       any
violation or nonperformance of any covenant or agreement of the Company under this Agreement.

 

Section 7.03.Limits
on Indemnification. The indemnification provided for in Section 7.02 shall be subject to the following limitations:

 

(a)       The
Company shall not be liable for any claim for indemnification pursuant to Section 7.02(a) unless and until the aggregate amount
of all indemnifiable Losses under Section 7.02(a) exceeds US$1 million, in which event the Company shall be required to pay or
be liable for all such Losses from the first dollar. The aggregate amount of all Losses for which the Company shall be liable pursuant
to Section 7.02(a) shall not exceed 30% of the aggregate amount of the Purchase Price that has been paid by the Investor.

 

(b)       Notwithstanding
the foregoing, the limitations set forth in Section 7.03(a) shall not apply to Losses arising out of or resulting from any inaccuracy
or breach of any Fundamental Reps.

 

    	 	18	 

     

    

 

Section
7.04.      Third-Party Claims. If an Indemnified Party shall receive notice of any
Action, audit, demand or assessment (each, a “Third-Party Claim”) against it or which may give rise to a
claim for Loss under this Article VII, within thirty (30) calendar days of the receipt of such notice, the Indemnified Party
shall give the Company, notice of such Third-Party Claim; provided, however, that the failure to provide such
notice shall not release the Company from any of its obligations under this Article VII except to the extent that the Company
is materially prejudiced by such failure and shall not relieve the Company from any other obligation or liability that it may
have to any Indemnified Party otherwise than under this Article VII. If the Company acknowledges in writing its obligation to
indemnify the Indemnified Party or Indemnified Parties hereunder against any Losses that may result from such Third-Party
Claim, then the Company shall be entitled to assume and control the defense of such Third-Party Claim at its or their expense
and through counsel of its or their choice if it or they give notice of such intention to do so to the Indemnified Party or
Indemnified Parties, as the case may be, within fourteen (14) calendar days of the receipt of notice from any
Indemnified Party of such Third-Party Claim; provided, however, that if there exists or is reasonably likely to
exist a conflict of interest that would make it inappropriate in the reasonable judgment of the Indemnified Party or
Indemnified Parties in its or their sole and absolute discretion for the same counsel to represent both the Indemnified Party
or Indemnified Parties and the Company, then the Indemnified Party or Indemnified Parties shall be entitled to retain its or
their own counsel in each jurisdiction for which the Indemnified Party determines counsel is required, at the expense of the
Company. In the event that the Company exercises the right to undertake any such defense against any such Third-Party Claim
as provided above, the Indemnified Party or Indemnified Parties shall cooperate with the Company in such defense and make
available to the Company, at the Company’s expense, all witnesses, pertinent records, materials and information in the
Indemnified Party’s possession or under the Indemnified Party’s control relating thereto as is reasonably
required by the Company. Similarly, in the event any Indemnified Party is, directly or indirectly, conducting the defense
against any such Third-Party Claim, the Company shall cooperate with the Indemnified Party or Indemnified Parties in such
defense and make available to any Indemnified Party, at the Company’s expense, all such witnesses, records, materials
and information in the Company’s possession or under the Company’s control relating thereto as is reasonably
required by any Indemnified Party. No Third-Party Claim may be settled (i) by any Indemnified Party without the prior written
consent of the Company (which shall not be unreasonably withheld or delayed) if the Company acknowledges in writing its or
their obligation to indemnify such Indemnified Party hereunder against any Losses that may result from such Third-Party
Claim or (ii) by the Company without the prior written consent of the Indemnified Party or Indemnified Parties, except, in
the case of (ii) only, where settlement of such Third-Party Claim (A) includes an unconditional release of the Indemnified
Party or Indemnified Parties from all liability arising out of such Action, audit, demand or assessment and (B) does not
include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any Indemnified
Party.

 

Section 7.05.      Exclusive
Remedy. Following the Closing, notwithstanding any other provision contained herein, this Article VII shall be the sole and
exclusive monetary remedy of the Investor for any and all claims arising out of or resulting from this Agreement, except that no
limitation or exceptions with respect to the obligations or liabilities on the Company in this Article VII shall apply to any claims
arising out of or resulting from fraud or willful misconduct on the part of the Company. Nothing in this Article VII or elsewhere
in this Agreement shall limit any Party’s right to specific performance or other equitable or non-monetary remedies.

 

ARTICLE VIII

TERMINATION

 

Section 8.01.      Termination.
This Agreement may be terminated at any time prior to the Closing by the mutual written consent of the Company and the Investor.

 

Section 8.02.      Effect
of Termination. In the event of termination of this Agreement pursuant to Section 8.01, this Agreement shall forthwith become
void and there shall be no liability under this Agreement on the part of any Party except that nothing herein shall relieve any
Party from liability for any breach of this Agreement that occurred before relevant termination and the terms of this Section 8.02
and Article IX shall survive any such termination.

 

    	 	19	 

     

    

 

ARTICLE IX

MISCELLANEOUS

 

Section 9.01.      Notices.
All notices, requests, claims, demands and other communications hereunder shall be in writing and shall be deemed duly given, made
or received on the date of delivery if delivered in person or by internationally recognized overnight courier service, or on the
date of confirmation of receipt of transmission by facsimile (provided that confirmation of transmission is mechanically
or electronically generated and kept on file by the sending Party), to the respective Parties at the following addresses (or at
such other address for a Party as shall be specified in a notice given in accordance with this Section 9.01):

 

(a)       If
to the Company, to:

 

Origin Agritech Limited

No. 21 Sheng Ming Yuan Road

Changping District

Beijing 102206, China

Attention: Cindy Xin Zhou

Facsimile: +86 10 5890 7577

 

with a copy (which shall not constitute notice) to:

 

Davis Polk & Wardwell LLP

2201 China World Office 2

1 Jian Guo Men Wai Avenue

Chao Yang District

Beijing 10004, China

Attention: Howard Zhang, Esq.

Facsimile: +86 10 8567 5102

 

(b)       If
to the Investor, to:

 

Long Han Investment Management Co., Ltd.

1 Chedaogou East Road

Qingdong Business Center Block C, Level 4

Haidian District

Beijing 100089, China

Attention: Shuangcheng Zhou

 

with a copy (which shall not constitute notice) to:

 

Dentons Law Firm

7th Floor, Building D, Parkview Green FangCaoDi 9

Dongdaqiao Road Chaoyang District

Beijing 100020, China

Attention: Shoushuang Li

 

    	 	20	 

     

    

 

Section 9.02.      Public
Announcements; Confidentiality.

 

(a)       Neither
the Company nor the Investor shall issue or cause the publication of any press release or other public announcement with respect
to the Transactions without the prior consent of the other Party (which consent shall not be unreasonably withheld, conditioned
or delayed), except as may be required by applicable Law or the rules and regulations of the NASDAQ, in each case, as determined
in the good faith judgment of the Party proposing to make such release (in which case such Party shall not issue or cause the publication
of such press release or other public announcement without prior consultation with the other Party reasonably in advance of such
public announcement).

 

(b)       For
a period of eighteen (18) months following the Closing, the Investor shall, and shall cause its Affiliates and their respective
Representatives to, hold in strict confidence any and all information, whether written or oral, concerning the Group Companies,
except to the extent that the Investor can show that such information (a) is generally available to and known by the public through
no fault of the Investor, any of its Affiliates or their respective Representatives; or (b) is lawfully acquired by the Investor,
any of its Affiliates or their respective Representatives from and after the Closing from sources which are not prohibited from
disclosing such information by a legal, contractual or fiduciary obligation. If the Investor or any of its Affiliates or their
respective Representatives are compelled to disclose any information by judicial or administrative process or by other requirements
of Law or applicable national securities exchange, the Investor shall promptly notify the Company in writing and shall disclose
only that portion of such information is legally required to be disclosed, provided that the Investor shall use commercially
reasonable efforts to obtain an appropriate protective order or other reasonable assurance that confidential treatment will be
accorded such information.

 

Section 9.03.      Amendment.
Any provision of this Agreement may be amended or waived prior to Closing if, but only if, such amendment or waiver is in writing
and is signed, in the case of an amendment, by each Party to this Agreement or, in the case of a waiver, by each Party against
whom the waiver is to be effective. No failure or delay by any Party in exercising any right, power or privilege hereunder shall
operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or
the exercise of any other right, power or privilege.

 

Section 9.04.      Taxes
and Expenses. Each Party shall pay all of its own fees and expenses (including attorneys’ fees) incurred in connection
with this Agreement and the Transactions. Except as otherwise provided in this Agreement or agree expressly among the Parties,
each Party shall be solely responsible for all Taxes accruing to such Party arising from this Agreement or the Transactions under
applicable Laws.

 

    	 	21	 

     

    

 

Section 9.05.      Assignment.
This Agreement and the rights and obligations of the Parties hereunder may not be assigned or delegated by the Company without
the Investor’s written consent or by the Investor without the Company’s written consent, provided that the Investor
may assign this Agreement and the rights and obligations of the Investor hereunder to any of its Affiliates. Any purported assignment
or delegation in violation of this Section 9.05 shall be null and void.

 

Section 9.06.      No
Third-Party Beneficiaries. Except for the provisions of Article VII relating to the Indemnified Parties, this Agreement shall
be binding upon and inure solely to the benefit of the Parties and their respective successors and permitted assigns and nothing
herein, express or implied, is intended to or shall confer upon any other Person any legal or equitable right, benefit or remedy
of any nature whatsoever.

 

Section 9.07.      Governing
Law; Arbitration.

 

(a)       This
Agreement shall be governed by, and construed in accordance with, the Laws of the State of New York without regard to its conflicts
of law principles thereof.

 

(b)       Any
dispute, controversy or claim arising out of or relating to this Agreement or its subject matter shall be finally settled by arbitration.
The place and seat of arbitration shall be Hong Kong, and the arbitration shall be administered by the Hong Kong International
Arbitration Centre (the “HKIAC”) in accordance with the HKIAC Administered Arbitration Rules then in force (the
 “HKIAC Rules”). The number of arbitrators shall be three (3). In the event that there are more than two parties
to an arbitration, one arbitrator shall be appointed by the Investor and one arbitrator shall be appointed by the Company. The
third arbitrator, who shall serve as chairperson of the arbitral tribunal, shall be selected by the mutual agreement of the first
two arbitrators. Any arbitrator that is not so appointed shall instead be appointed in accordance with the HKIAC Rules. The language
to be used in the arbitration proceedings shall be English. The award of the arbitral tribunal shall be final, conclusive and binding
upon the Parties. Judgment upon any award may be entered and enforced in any court having jurisdiction over a Party or any of its
assets. For the purpose of the enforcement of an award, the Parties irrevocably and unconditionally submit to the jurisdiction
of any competent court and waive any defenses to such enforcement, including any defenses based on lack of personal jurisdiction
or inconvenient forum.

 

Section 9.08.      Entire
Agreement. This Agreement, the Investor Rights Agreement and the confidentiality agreement, dated as of September 2018, by
and between the Company and the Investor constitute the entire agreement between the Parties with respect to the subject matter
of this Agreement and supersede all prior agreements and understandings, both oral and written, between the Parties and/or their
Affiliates with respect to the subject matter of this Agreement.

 

    	 	22	 

     

    

 

Section 9.09.      Severability.
If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced under any Law or public policy,
all other terms and provisions of this Agreement shall nevertheless remain in full force and effect for so long as the economic
or legal substance of the Transactions is not affected in any manner materially adverse to any Party. Upon such determination that
any term or other provision is invalid, illegal or incapable of being enforced, the Company and the Investor shall negotiate together
in good faith to modify this Agreement so as to effect the original intent of the Company and the Investor as closely as possible
in an acceptable manner in order that the Transactions are consummated as originally contemplated to the greatest extent possible.

 

Section 9.10.      Counterparts.
This Agreement may be executed and delivered (including by electronic transmission in PDF format or by facsimile transmission)
in one or more counterparts, and by the Parties in separate counterparts, each of which when executed shall be deemed to be an
original but all of which taken together shall constitute one and the same agreement.

 

Section 9.11.      Specific
Performance. The Parties acknowledge and agree that irreparable damage would occur, no adequate remedy at law would exist and
damages would be difficult to determine if any of the provisions of this Agreement are not performed in accordance with their specific
terms. Accordingly, in addition to any other right or remedy to which a Party may be entitled, at law or in equity, it shall be
entitled to seek enforcement of any provision of this Agreement by a decree of specific performance and to seek temporary, preliminary
and permanent injunctive relief to prevent breaches or threatened breaches of any of the provisions of this Agreement, without
the necessity of proving the inadequacy of money damages as a remedy and without the necessity of posting any bond or other undertaking.
The Parties further agree not to assert that a remedy of specific performance is unenforceable, invalid, contrary to applicable
Law or inequitable for any reason, nor to assert that a remedy of monetary damages would provide an adequate remedy for any such
breach.

 

[Remainder of Page Intentionally Left
Blank]

 

    	 	23	 

     

    

 

IN WITNESS WHEREOF, the Parties have caused
this Agreement to be duly executed by their respective authorized officers as of the day and year first above written.

 

	 	ORGIN AGRITECH LIMITED
	 	 
	 	By:	/s/ Zheng James Chen
	 	 	Name:	Zheng James Chen
	 	 	Title:	Chief Executive Officer

 

 

[Signature Page to Share Subscription
Agreement]

 

     

     

    

 

 

[Signature Page to Share Subscription
Agreement]

 

     

     

    

 

Exhibit A – Form of Investor Rights
Agreement

 

    	 	Exhibit A	 

     

    

 

EXECUTION VERSION

 

INVESTOR RIGHTS AGREEMENT

 

THIS INVESTOR RIGHTS AGREEMENT (this “Agreement”)
is made as of October 16, 2018 by and between:

 

		(1)	Origin Agritech Limited, a company incorporated under the laws of the British Virgin Islands
(the “Company”); and

 

		(2)	Long Han Investment Management Co., Ltd. (隆瀚投资管理有限公司),
a company incorporated under the laws of the People’s Republic of China (the “Investor”).

 

The parties listed above are referred to herein collectively
as “Parties” and individually as a “Party.”

 

RECITALS

 

		A.	The Company and the Investor entered into a Share Subscription Agreement, dated as of October 16,
2018 (the “Share Subscription Agreement”), pursuant to which, among other things, the Company has agreed to
issue and sell to the Investor certain Ordinary Shares; and

 

		B.	In connection with and as a closing deliverable at the Closing (as defined below) contemplated
by the Share Subscription Agreement, the Company and the Investor have agreed to enter into this Agreement.

 

WITNESSETH

 

NOW, THEREFORE, in
consideration of the premises set forth above, the mutual promises and covenants set forth herein and other good and valuable consideration,
the receipt and adequacy of which are hereby acknowledged, the Parties agree as follows:

 

		1.	Interpretation 

 

1.1          Definitions. The following terms shall have the meanings ascribed to them below:

 

“Additional Lockup Date”
shall have the meaning ascribed to this term in Section 3.1.

 

“Affiliate”
means, with respect to any Person, any Person that controls, is controlled by, or is under common control with such Person. As
used herein, the term “control” (including the terms “controlling,” “controlled
by” and “under common control with”) means the possession, directly or indirectly, and individually
or together with any other Person, of the power to direct or to cause the direction of the management and policies of a Person,
whether through ownership of voting securities or other interests, by contract or otherwise.

 

“Aggregate Ownership”
means, with respect to any Person, the total number of Ordinary Shares, the voting power or investment power over which is directly
or indirectly, through any contract, arrangement, understanding, relationship or otherwise, held, possessed or shared (without
duplication) by such Person as of the date of such calculation.

 

     

     

    

 

“Aggregate Ownership Percentage”
means, with respect to the Investor, the quotient (expressed as a percentage) obtained by dividing (i) the Aggregate Ownership
held by the Investor, by (ii) the Aggregate Ownership of all holders of Ordinary Shares.

 

“At-the-Market
Offering” means a Registration in which securities of the Company are sold to the public through one or more investment
banks or financial advisors as agent to the selling shareholder (but not as underwriter on a firm commitment basis).

 

“Beneficially
Own” or “Beneficial Ownership” means, with respect to any securities, having “beneficial ownership”
of such securities as determined pursuant to Rule 13d-3 under the Exchange Act.

 

“Blackout
Period” means (i) any period during which directors and executive officers of the Company are not permitted to trade
under the insider trading policy of the Company then in effect; provided that the foregoing restriction shall not apply
with respect to the Investor if the Investor no longer has a right to designate a member of the Board pursuant to this Agreement
and (ii) in the event that the Company determines in good faith that the registration would reasonably be expected to materially
and adversely affect or materially interfere with any bona fide material financing of the Company or any material transaction under
consideration by the Company or would require disclosure of material information that has not been disclosed to the public, a period
of up to sixty (60) days (the Blackout Period described in this clause (ii) shall count as an “Unscheduled Blackout Period”).
The Unscheduled Blackout Period may not occur more than twice in any period of fifteen (15) consecutive months.

 

“Board” or “Board of Directors”
means the board of directors of the Company.

 

“Business
Day” means any day that is not a Saturday, a Sunday or other day on which banks are required or authorized by Law to
be closed in the city of Beijing, Hong Kong or New York.

 

“Closing” has the meaning set forth
in the Share Subscription Agreement.

 

“Company Competitors”
means the entities, enterprises and businesses listed in Schedule I hereof and any Affiliates of any such entity, enterprise
or business, which list may be updated by the Board.

 

“Company Securities”
means (i) Ordinary Shares, (ii) securities convertible into or exercisable or exchangeable for Ordinary Shares and (iii) any options,
warrants or other rights to acquire Ordinary Shares, whether issued before, at or after the date hereof.

 

“Exchange Act” means the United
States Securities Exchange Act of 1934, as amended.

 

“Existing
Shares” means the Ordinary Shares held by the Investor or its Affiliates immediately prior to the Closing.

 

“Form F-3”
means Form F-3 promulgated by the SEC under the Securities Act or any successor form or substantially similar form then in effect.

 

    	 	2	 

     

    

 

“Governmental
Authority” means any federal, national, foreign, supranational, state, provincial, local or other governmental, regulatory
or administrative authority, agency or commission or any court, tribunal, or judicial or arbitral body.

 

“Governmental
Order” means any writ, judgment, decree, injunction, award or similar order of any Government Authority (in each case
whether preliminary or final).

 

“HKIAC” shall have the meaning ascribed
to this term in Section 7.2.

 

“HKIAC Rules” shall have the meaning
ascribed to this term in Section 7.2.

 

“Holder”
means the Investor or any of its Permitted Transferees, so long as such Person holds Registrable Securities.

 

“Initial Investor
Ownership Percentage” means the quotient (expressed as a percentage) obtained by dividing (i) the Aggregate Ownership
of the Investor as of the date of such calculation, by (ii) the Aggregate Ownership of the Investor as of the Closing (as proportionally
adjusted to give effect to any stock split, stock dividend, recapitalization or any similar transaction after the Closing).

 

“Investor Nominee” shall have the
meaning ascribed to this term in Section 5.1(a).

 

“Law”
means any federal, national, foreign, supranational, state, provincial, local or similar statute, law, treaty, ordinance, regulation,
rule, code, order, requirement or rule of law (including common law) or any Governmental Order.

 

“Lockup Date” shall have the meaning
ascribed to this term in Section 3.1.

 

“Lockup Shares” means collectively,
the Purchased Shares and the Existing Shares.

 

“Loss” shall have the meaning ascribed
to this term in Section 2.8.

 

“New Securities”
means any Ordinary Shares or other voting shares of the Company and rights, options or warrants to purchase such Ordinary Shares
or securities of any type whatsoever that are, or may become, convertible or exchangeable into such Ordinary Shares or other voting
shares; provided that the term “New Securities” does not include (i) Company Securities issued to the employees, consultants,
officers or directors of the Company or its Subsidiaries, or which have been reserved for issuance, pursuant to each of the Company’s
equity based incentive plans adopted in 2005, 2009 and 2014, respectively; (ii) Ordinary Shares issued to all holders of the Company
on a pro rata basis in connection with any share split, share dividend, combination, reclassification or recapitalization of the
Company; or (iii) Ordinary Shares issued upon the conversion of any loan amount pursuant to the Promissory Note.

 

“Ordinary
Shares” means shares of common stock of nil par value per share in the capital of the Company.

 

“Permitted
Transferee” means any Affiliate of the Investor for so long as such transferee remains an Affiliate of the Investor at
all times following the applicable transfer. For the avoidance of doubt, Permitted Transferee includes any entities advised or
managed by the Investor or its Affiliates.

 

    	 	3	 

     

    

 

“Person”
means any individual, partnership, firm, corporation, limited liability company, association, trust, unincorporated organization,
Governmental Authority or other entity.

 

“Piggyback Registration” shall
have the meaning ascribed to this term in Section 5.1(b).

 

“Promissory
Note” means the Promissory Note, dated as of July 5, 2017, by and between the Company and L2 Capital, LLC, including
any amendment, renewal, replacement, or successor agreement and any future agreement that confers similar rights.

 

“Prospectus”
means the prospectus included in any Registration Statement, all amendments and supplements to such prospectus, including post-effective
amendments, and all other material incorporated by reference in such prospectus.

 

“Purchased
Shares” means all the Ordinary Shares acquired by the Investor pursuant to the Share Subscription Agreement.

 

“Registrable
Securities” means all of the Ordinary Shares acquired by the Investor pursuant to the Share Subscription Agreement; provided
that any such Ordinary Shares shall cease to be Registrable Securities if (i) they have been registered and sold pursuant to an
effective Registration Statement, (ii) they have been transferred by a Holder in a transaction in which the Holder’s rights
under this Agreement are not, or cannot be, assigned, (iii) they may be sold pursuant to Rule 144 under the Securities Act without
limitation thereunder on volume or manner of sale or (iv) they have ceased to be outstanding.

 

“Registration”
means a registration with the SEC of the offer and sale to the public of Registrable Securities under a Registration Statement.
The terms “Register,” “Registered” and “Registering” shall have a correlative
meaning.

 

“Registration
Expenses” shall mean all expenses incident to the Company’s performance of or compliance with this
Agreement, including all (i) registration, qualification and filing fees; (ii) expenses incurred in connection with the
preparation, printing and filing under the Securities Act of the Registration Statement, any Prospectus and any issuer free
writing prospectus and the distribution thereof; (iii) the reasonable fees and expenses of the Company’s counsel and
independent accountants; (iv) the fees and expenses incurred in connection with the registration or qualification and
determination of eligibility for investment of the Ordinary Shares under the state blue sky laws (including the related fees
and expenses of counsel); (v) the costs and charges of any transfer agent and any registrar; (vi) all expenses and
application fees incurred in connection with any filing with, and clearance of an offering by, Financial Industry Regulatory
Authority, Inc.; (vii) expenses incurred in connection with any “road show” presentation to potential investors;
(viii) printing expenses, messenger, telephone and delivery expenses; and (ix) fees and expenses of listing any Registrable
Securities on any securities exchange on which the Ordinary Shares are then listed; but in each case excluding any Selling
Expenses.

 

    	 	4	 

     

    

 

“Registration Statement” means
any registration statement of the Company filed with, or to be filed with, the SEC under the rules and regulations promulgated
under the Securities Act, including the related Prospectus, amendments and supplements to such registration statement, including
post-effective amendments, and all exhibits and all material incorporated by reference in such registration statement.

 

“Replacement Nominee” shall have
the meaning ascribed to this term in Section 5.1(b).

 

“Representatives”
means, with respect to any Person, such Person’s Affiliates and such Person and its Affiliates’ respective directors,
officers, employees, members, partners, accountants, consultants, advisors, attorneys, agents and other representatives.

 

“SEC” means the United States Securities
and Exchange Commission.

 

“Securities Act” means the United
States Securities Act of 1933, as amended.

 

“Selling Expenses”
means (i) all underwriting discounts, selling commissions and transfer taxes applicable to the sale of Registrable Securities hereunder
and (ii) any fees and expenses of legal counsel or other advisors of the Holders.

 

“Shelf Registration”
means a Registration Statement of the Company on Form F-3 for an offering to be made on a delayed or continuous basis of Ordinary
Shares pursuant to Rule 415 under the Securities Act (or similar provisions then in effect).

 

“Takedown Notice” shall have the
meaning ascribed to this term in Section 2.1(b).

 

“Transfer” shall have the meaning
ascribed to this term in Section 3.1.

 

“Underwritten
Offering” means a Registration in which securities of the Company are sold to an underwriter or underwriters on a firm
commitment basis for reoffering to the public.

 

1.2           Interpretation.
For all purposes of this Agreement, except as otherwise expressly provided, (i) the terms defined in this Section 1 shall
have the meanings assigned to them in this Section 1 and include the plural as well as the singular, (ii) all references
in this Agreement to designated “Sections” and other subdivisions are to the designated Sections and other subdivisions
of the body of this Agreement, (iii) pronouns of either gender or neuter shall include, as appropriate, the other pronoun forms,
(iv) the words “herein,” “hereof” and “hereunder” and other words of similar import refer to
this Agreement as a whole and not to any particular Section or other subdivision, (v) all references in this Agreement to designated
schedules, exhibits and annexes are to the schedules, exhibits and annexes attached to this Agreement unless explicitly stated
otherwise, (vi) “or” is not exclusive, (vii) the term “including” will be deemed to be followed by “,
but not limited to,” (viii) the terms “shall,” “will,” and “agrees” are mandatory, and
the term “may” is permissive, and (ix) the term “day” means “calendar day.”

 

    	 	5	 

     

    

 

		2.	Registration Rights. 

 

 2.1          Shelf Registration.

 

(a)       Shelf
Registration. To the extent permitted under applicable Law, upon a written request by the Investor, the Company shall take
all necessary actions as reasonably required by the Investor to prepare and file a Shelf Registration covering the offering and
sale of the Registrable Securities of the Investor pursuant to Rule 415 under the Securities Act no later than the Lockup Date
and the Company shall use commercially reasonable efforts to cause such Shelf Registration to become effective or declared effective
by the SEC as promptly as practicable after such filing. Nothing in this Section 2 shall be construed as permitting any Transfer
that is prohibited under Section 3.

 

  The Company shall provide
such Shelf Registration (and each amendment or supplement thereto, and each request for acceleration of effectiveness thereof)
to the Investor and its counsel at a reasonable time prior to its filing or other submission and shall not file or submit the same
in a form to which the Investor or its counsel reasonably objects in writing within two (2) Business Days after the receipt thereof.

 

  The Company shall notify
the Investor by facsimile or email as promptly as practicable after any such Shelf Registration becomes or is declared effective.

 

(b)       Shelf
Takedown. After the Lockup Date (or an earlier date agreed by the Company in writing), if any Holder of Registrable Securities
included on a Shelf Registration delivers a written notice to the Company specifying the kind and number of such Registrable Securities
such Holder wishes to sell or distribute (the “Takedown Notice”), the Company shall take all actions reasonably
requested by such Holder, including amending or supplementing such Shelf Registration, as may be necessary to enable such Registrable
Securities to be sold or distributed in accordance with the intended method of distribution set forth in the Takedown Notice, including
an Underwritten Offering, as expeditiously as practicable; provided, however, that (i) the Holders may not require
the Company to effect a shelf takedown that is an Underwritten Offering unless the Registrable Securities to be registered exceed
20% of the total Registrable Securities as of the date of this Agreement, (ii) the Holders may not require the Company to effect
more than two shelf takedowns that are Underwritten Offerings in any 12-month period, (iii) the Holders may not require the Company
to effect more than three shelf takedowns (other than shelf takedowns that are Underwritten Offerings) in any 12-month period and
(iv) the Holders may not require the Company to effect more than five shelf takedowns that are Underwritten Offerings.

 

(c)       Blackout.
The Company shall be entitled to postpone (upon prior written notice to the Investor) the filing or the effectiveness of a Registration
Statement for any Registration or suspend the use of any Registration Statement in the event of a Blackout Period until the expiration
of the applicable Blackout Period. Upon notice by the Company to the Holders of a Blackout Period, each Holder shall keep the fact
of any such notice strictly confidential and, during any Blackout Period, promptly halt any offer, sale, trading or transfer by
it of any Registrable Securities pursuant to the Shelf Registration for the duration of the Blackout Period set forth in such notice
(or until such Blackout Period shall be earlier terminated in writing by the Company) and promptly halt any use, publication, dissemination
or distribution of any Prospectus covering any Registrable Securities for the duration of the Blackout Period and, if so directed
by the Company, shall deliver to the Company any copies then in its possession of any such Prospectus. The Company shall use commercially
reasonable efforts to terminate any postponement or suspension under any Blackout Period (including any Unscheduled Blackout Period)
as promptly as practicable.

 

    	 	6	 

     

    

 

(d)       Effective
Registration. Subject to the applicability of Blackout Periods, the Company shall use its commercially reasonable efforts to
keep the Shelf Registration for purposes of Section 2.1(a) continuously effective under the Securities Act in order to permit
the Prospectus forming a part thereof to be usable by Holders until the termination of the registration rights pursuant to Section
2.10.

 

(e)       Underwritten
Offering. In the event that a Holder intends to distribute the Registrable Securities in a Registration by means of an Underwritten
Offering, no Holder may include Registrable Securities in such Registration unless such Holder, subject to the limitations set
forth in Section 2.6, (i) agrees to sell its Registrable Securities on the basis provided in the applicable underwriting
arrangements; (ii) completes and executes all questionnaires, powers of attorney, indemnities, underwriting agreements and other
documents reasonably required under the terms of such underwriting arrangements; and (iii) cooperates with the Company’s
reasonable requests in connection with such Registration (it being understood that the Company’s failure to perform its obligations
hereunder, which failure is caused by such Holder’s failure to cooperate, will not constitute a breach by the Company of
this Agreement).

 

(f)       Priority
of Securities in an Underwritten Offering. If the managing underwriter or underwriters of a proposed Underwritten Offering
informs the Company and the Holders with Registrable Securities in the proposed Underwritten Offering in writing that, in its or
their opinion, the number of securities requested to be included in such Underwritten Offering exceeds the number that can be sold
in such Underwritten Offering without being likely to have a significant adverse effect on the price, timing or distribution of
the securities offered or the market for the securities offered, then the number of securities to be included in such Underwritten
Offering shall be reduced to the extent necessary to reduce the total number of securities to be included in such offering to the
number recommended by the managing underwriter or underwriters in the following order of priority: first, there shall be excluded
from the Underwritten Offering any securities to be sold for the account of any selling securityholder, including the Holders,
that have been requested to be included therein pursuant to piggyback registration rights (including Section 2.2), pro rata
based on the number of securities owned by such selling securityholder; second, there shall be excluded from the Underwritten Offering
any securities to be sold for the account of selling securityholders, including the Holders, that originally requested the Underwritten
Offering, pro rata based on the number of securities owned by such selling securityholder to the extent there is more than one
such initiating selling securityholder; and finally, there shall be excluded from the Underwritten Offering any securities to be
sold for the account of the Company.

 

(g)       Eligibility
for Form F-3 and WKSI Status. The Company represents and warrants to the Investor as of the date hereof that the Company meets
the requirements for use of Form F-3 under the Securities Act and the Company is a “well-known seasoned issuer” as
defined in Rule 405 under the Securities Act. The Company shall use commercially reasonable efforts to maintain its eligibility
for a Shelf Registration under Form F-3 and in the event that the Company fails to meet the requirements for use of Form F-3, the
Company shall be required to perform its obligations under this Agreement as if all references to “Form F-3” were replaced
by “Form F-1” for the purposes of the definition of “Shelf Registration”.

 

    	 	7	 

     

    

 

2.2           Piggyback
Registrations.

 

(a)       Participation.
After the Lockup Date (or an earlier date agreed by the Company in writing), if the Company proposes to file a Prospectus as part
of any Registration Statement under the Securities Act with respect to any offering of Company Securities for its own account and/or
for the account of any other Persons (other than a Registration (i) under Section 2.1 hereof, (ii) pursuant to a Registration
Statement on Form S-8 (or other registration solely relating to an offering or sale to employees or directors of the Company pursuant
to any employee stock plan or other employee benefit arrangement) or Form F-4, Form S-4 or similar form that relates to a transaction
subject to Rule 145 under the Securities Act, (iii) pursuant to any form that does not include substantially the same information
as would be required to be included in a Registration Statement covering the sale of Registrable Securities, (iv) in connection
with any dividend reinvestment or similar plan, (v) for the sole purpose of offering securities to another entity or its security
holders in connection with the acquisition of assets or securities of such entity or any similar transaction, or (vi) that relates
to an offering of Company Securities that is not underwritten and that occurs at a time when a Shelf Registration is effective
in accordance with Section 2.1(a)), then the Company shall give written notice of such proposed filing to the Investor on
behalf of each Holder as soon as practicable (but in any event at least ten (10) Business Days prior to the proposed date of printing
the preliminary Prospectus), and such notice shall offer such Holders the opportunity to Register under such Registration Statement
such number of Registrable Securities as each such Holder may request in writing (a “Piggyback Registration”).
Subject to this Section 2.2(a) and Section 2.2(c), the Company shall use commercially reasonable efforts to include
in such Registration Statement all such Registrable Securities that are requested to be included therein within six (6) Business
Days after the date of any such notice. If the offering pursuant to a Registration Statement pursuant to this Section 2.2(a)
is to be an Underwritten Offering, then each Holder making a request for a Piggyback Registration pursuant to this Section
2.2(a) shall, and the Company shall use commercially reasonable efforts to coordinate arrangements with the underwriters so
that each such Holder may, participate in such Underwritten Offering. If the offering pursuant to such Registration Statement is
to be on any other basis, then each Holder making a request for a Piggyback Registration pursuant to this Section 2.2(a)
shall, and the Company shall use commercially reasonable efforts to coordinate arrangements so that each such Holder may, participate
in such offering on such basis. If the Company files a Shelf Registration for its own account and/or for the account of any other
Persons, the Company agrees that it shall use its commercially reasonable efforts to include in such Registration Statement such
disclosures as may be required by Rule 430B under the Securities Act in order to ensure that the Holders may be added to such Shelf
Registration at a later time through the filing of a Prospectus supplement rather than a post-effective amendment.

 

(b)       Right
to Withdraw. Each Holder shall have the right to withdraw such Holder’s request for inclusion of its Registrable Securities
in any Underwritten Offering pursuant to this Section 2.2 at any time prior to the execution of an underwriting agreement
with respect thereto by giving written notice to the Company of such Holder’s request to withdraw and, subject to the preceding
clause, each Holder shall be permitted to withdraw all or part of such Holder’s Registrable Securities from a Piggyback Registration
at any time prior to the printing of the preliminary Prospectus.

 

    	 	8	 

     

    

 

(c)       Priority
of Piggyback Registration. If the managing underwriter or underwriters of any proposed Underwritten Offering of a class of
Registrable Securities included in a Piggyback Registration informs the Company and the Holders in writing that, in its or their
opinion, the number of securities of such class which such Holder and any other Persons intend to include in such Underwritten
Offering exceeds the number which can be sold in such Underwritten Offering without being likely to have a significant adverse
effect on the price, timing or distribution of the securities offered or the market for the securities offered, then the securities
to be included in such Underwritten Offering shall be reduced to the extent necessary to reduce the total number of securities
to be included in such offering to the number recommended by the managing underwriter or underwriters in the following order of
priority: first, there shall be excluded from the Underwritten Offering any securities to be sold for the account of any selling
securityholder, including the Holders, that have been requested to be included therein pursuant to piggyback registration rights
(including this Section 2.2), pro rata based on the number of securities owned by such selling securityholder; second, there
shall be excluded from the Underwritten Offering any securities to be sold for the account of selling securityholders, including
the Holders, that originally requested the Underwritten Offering, pro rata based on the number of securities owned by such selling
securityholder to the extent there is more than one such initiating selling securityholder; and finally, there shall be excluded
from the Underwritten Offering any securities to be sold for the account of the Company.

 

(d)       Determination
Not to Conduct Offering. If at any time after giving a Piggyback Registration notice and prior to the filing of a final prospectus
supplement in connection with such offering, the Company shall determine for any reason not to offer the securities originally
intended to be included in such offering, the Company may, at its election, give written notice of such determination to the Investor
and thereupon the Company shall be relieved of its obligation to include any Holder’s Registrable Securities in such offering.

 

2.3           Notification
to Holder. The Company shall advise each Holder promptly in writing of the existence of any fact and the happening of any event
that makes any statement of a material fact made in any Registration Statement or Prospectus untrue, or that requires the making
of any additions to or changes in any Registration Statement or Prospectus in order to make the statements therein not misleading
and in such event the Company shall prepare and file with the SEC, as soon as reasonably practicable, an amendment to such Registration
Statement or an amendment or supplement to such Prospectus or a report on Form 6-K, as the case may be, so that, as so amended
or supplemented, such Registration Statement and such Prospectus will not contain an untrue statement of a material fact or omit
to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances
then existing, not misleading. Upon receipt of such written advice, each Holder shall discontinue and refrain from making any sales
of Registrable Securities, until such time as the Company advises such Holder that such Registration Statement or such Prospectus
no longer contains an untrue statement or omission of a material fact, and if so directed by the Company, such Holder will deliver
to the Company (at the Company’s expense) all copies of the Prospectus covering such Registrable Securities current at the
time of receipt of such notice. The period during which the sales of Registrable Securities are suspended pursuant to the foregoing
sentence shall count as an Unscheduled Blackout Period.

 

    	 	9	 

     

    

 

2.4           Holder
Information. As a condition precedent to any Registration hereunder, the Company may require each Holder as to which any Registration
is being effected to furnish to the Company, and each such Holder agrees to furnish to the Company, such information regarding
the distribution of such securities and such other information relating to such Holder, its ownership of Registrable Securities
and other matters as the Company may from time to time reasonably request in writing to enable the Company to comply with the provisions
of this Agreement.

 

2.5          Holdback
Agreements. Each of the Company and the Holders agrees, upon reasonable request from the managing underwriter or underwriters
in connection with any Registration for an Underwritten Offering of the Company’s securities (other than pursuant to a registration
statement on Form F-4, Form S-4 or any similar or successor form or pursuant to a registration solely relating to an offering and
sale to employees or directors of the Company pursuant to any employee stock plan or other employee benefit plan arrangement),
not to effect (other than pursuant to such Registration) any public sale or distribution of Registrable Securities, including,
but not limited to, any sale pursuant to Rule 144, or make any short sale of, loan, grant any option for the purchase of, or otherwise
dispose of, any Registrable Securities, any other Company Securities without the prior written consent of the managing underwriters
during such period as reasonably requested by the managing underwriters (but in no event longer than the seven days before and
the 30 days after the pricing of such Underwritten Offering).

 

2.6          Underwriting
Agreement in Underwritten Offerings. If requested by the managing underwriters for any Underwritten Offering, the Company and
the participating Holders shall enter into an underwriting agreement in customary form with such underwriters for such offering.

 

2.7          Registration
Expenses. In the case of any Registration of Registrable Securities required pursuant to this Agreement (including any Registration
that is delayed or withdrawn) or proposed Underwritten Offering pursuant to this Agreement, the Company shall pay all Registration
Expenses regardless of whether the Registration Statement becomes effective or the Underwritten Offering is completed; provided,
however, that in the case of any proposed shelf takedown pursuant to this Agreement that is an Underwritten Offering or
an At-the-Market Offering, the Investor shall pay such out-of-pocket Registration Expenses (other than Registration Expenses to
the extent such Registration Expenses would have been incurred by the Company if the shelf takedown were not an Underwritten Offering
or At-the-Market Offering) on a pro rata basis with reference to the number of the Registered Securities being offered by the Investor
in such shelf takedown and promptly reimburse such expenses to the Company upon request regardless of whether such Underwritten
Offering or At-the-Market Offering is completed. The Company shall have no obligation to pay any Selling Expenses.

 

    	 	10	 

     

    

 

 2.8           Indemnification.

 

(a)       Indemnification
by the Company. The Company agrees to indemnify and hold harmless, to the full extent permitted by law, each Holder and such
Holder’s officers, directors, employees, advisors, Affiliates and agents and each Person who controls (within the meaning
set forth in the Securities Act or the Exchange Act) such Holder from and against any and all losses, claims, damages, liabilities
(or actions in respect thereof) and expenses, joint or several (including reasonable costs of investigation and legal expenses)
(each, a “Loss” and collectively “Losses”) arising out of or based upon (i) any untrue or
alleged untrue statement of a material fact contained in any Registration Statement under which the sale of such Registrable Securities
was Registered under the Securities Act (including any final or preliminary Prospectus contained therein or any amendment thereof
or supplement thereto or any documents incorporated by reference therein), or any such statement made in any free writing prospectus
(as defined in Rule 405 under the Securities Act) that the Company has filed or is required to file pursuant to Rule 433(d) of
the Securities Act, or (ii) any omission or alleged omission to state therein a material fact required to be stated therein or
necessary to make the statements therein (in the case of a Prospectus, preliminary Prospectus or free writing prospectus, in light
of the circumstances under which they were made) not misleading; provided, however, that the Company shall not be
liable to any particular indemnified party in any such case to the extent that any such Loss arises out of or is based upon an
untrue statement or alleged untrue statement or omission or alleged omission made in any such Registration Statement (including
any final or preliminary Prospectus contained therein or any amendment thereof or supplement thereto or any documents incorporated
by reference therein) or any such statement made in any free writing prospectus in reliance upon and in conformity with written
information furnished to the Company by such indemnified party expressly for use in the preparation thereof. This indemnity shall
be in addition to any liability the Company may otherwise have. Such indemnity shall remain in full force and effect regardless
of any investigation made by or on behalf of such Holder or any indemnified party and shall survive the transfer of such securities
by such Holder.

 

(b)       Indemnification
by the Selling Holder. Each selling Holder agrees (severally and not jointly) to indemnify and hold harmless, to the full extent
permitted by law, the Company and the Company’s directors, officers, employees, advisors, Affiliates and agents and each
Person who controls (within the meaning set forth in the Securities Act or the Exchange Act) the Company from and against any Losses
arising out of or based upon (i) any untrue or alleged untrue statement of a material fact contained in any Registration Statement
under which the sale of such Registrable Securities was Registered under the Securities Act (including any final or preliminary
Prospectus contained therein or any amendment thereof or supplement thereto or any documents incorporated by reference therein),
or any such statement made in any free writing prospectus that the Company has filed or is required to file pursuant to Rule 433(d)
of the Securities Act, or (ii) any omission or alleged omission to state therein a material fact required to be stated therein
or necessary to make the statements therein (in the case of a Prospectus, preliminary Prospectus or free writing prospectus, in
light of the circumstances under which they were made) not misleading to the extent, but, in each case (i) or (ii), only to the
extent, that such untrue statement or alleged untrue statement or omission or alleged omission is made in reliance upon and in
conformity with any written information furnished by such selling Holder to the Company expressly for inclusion in such Registration
Statement, Prospectus, preliminary Prospectus or free writing prospectus. This indemnity shall be in addition to any liability
the selling Holder may otherwise have. Such indemnity shall remain in full force and effect regardless of any investigation made
by or on behalf of the Company or any indemnified party.

 

    	 	11	 

     

    

 

(c)       Conduct
of Indemnification Proceedings. Any Person seeking indemnification hereunder will (i) give prompt written notice to the indemnifying
party of any claim with respect to which it seeks indemnification (it being understood that any delay or failure to so notify the
indemnifying party shall relieve the indemnifying party of its obligations hereunder to the extent that it is materially prejudiced
by reason of such delay or failure) and (ii) permit such indemnifying party to assume the defense of such claim with counsel reasonably
satisfactory to the indemnified party; provided, however, that any Person entitled to indemnification hereunder shall
have the right to select and employ separate counsel and to participate in the defense of such claim, but the fees and expenses
of such counsel shall be at the expense of such Person unless (a) the indemnifying party has agreed in writing to pay such fees
or expenses, (b) the indemnifying party shall have failed to assume the defense of such claim within 15 Business Days after receipt
of notice of such claim from the Person seeking indemnification hereunder or fails to employ counsel reasonably satisfactory to
such Person within 15 Business Days after receipt of notice of such claim or to pursue the defense of such claim in a reasonably
vigorous manner, (c) the named parties to any proceeding include both such indemnified and the indemnifying party and the indemnified
party has reasonably concluded (based on written advice of counsel) that there may be legal defenses available to it or other indemnified
parties that are different from or in addition to those available to the indemnifying party, or (d) in the reasonable judgment
of any such Person, based upon written advice of its counsel, a conflict of interest may exist between such Person and the indemnifying
party with respect to such claims (in which case, if the Person notifies the indemnifying party in writing that such Person elects
to employ separate counsel at the expense of the indemnifying party, the indemnifying party shall not have the right to assume
the defense of such claim on behalf of such Person). If such defense is not assumed by the indemnifying party, the indemnifying
party will not be subject to any liability for any settlement made without its consent, but such consent shall not be unreasonably
withheld, conditioned or delayed. If the indemnifying party assumes the defense, the indemnifying party shall not have the right
to settle such action or enter into any judgment without the consent of the indemnified party, which consent shall not be unreasonably
withheld, conditioned or delayed, unless such settlement or judgment (i) includes as an unconditional term thereof the giving by
the claimant or plaintiff to such indemnified party of an unconditional release from all liability in respect to such claim or
litigation, (ii) does not include a statement as to or an admission of fault, culpability or failure to act, by or on behalf of
any indemnified party and (iii) does not provide for any action on the part of any party other than the payment of money damages
which is to be paid in full by the indemnifying party. It is understood that the indemnifying party or parties shall not, in connection
with any proceeding or related proceedings in the same jurisdiction, arising out of the same general allegations or circumstances,
be liable for the fees and expenses of more than one separate firm (in addition to one local counsel) at any one time from all
such indemnified party or parties unless (x) the employment of more than one counsel has been authorized in writing by the indemnifying
party or parties, (y) an indemnified party has reasonably concluded (based on written advice of counsel) that there may be legal
defenses available to it that are different from or in addition to those available to the other indemnified parties or (z) a conflict
or potential conflict exists or in the reasonable judgment of such Person may exist (based on advice of counsel to an indemnified
party) between such indemnified party or parties and the other indemnified parties, in each of which cases the indemnifying party
shall be obligated to pay the reasonable fees and expenses of such additional counsel.

 

(d)       Contribution.
If for any reason the indemnification provided for in Section 2.8(a) or Section 2.8(b) is unavailable to an indemnified
party or insufficient to hold it harmless as contemplated by Section 2.8(a) or Section 2.8(b), then the indemnifying
party shall, in lieu of indemnifying such indemnified party thereunder, contribute to the amount paid or payable by the indemnified
party as a result of such Loss in such proportion as is appropriate to reflect the relative fault of the indemnifying party on
the one hand and the indemnified party on the other hand in connection with the statements or omissions which resulted in such
Loss as well as any other relevant equitable considerations. The relative fault shall be determined by reference to, among other
things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material
fact relates to information supplied by the indemnifying party or the indemnified party and the parties’ relative intent,
knowledge, access to information and opportunity to correct or prevent such untrue statement or omission. The parties hereto agree
that it would not be just and equitable if contribution pursuant to this Section 2.8(d) were determined by pro rata allocation
or by any other method of allocation that does not take account of the equitable considerations referred to in this Section
2.8(d). No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall
be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation. The amount paid or payable
by an indemnified party hereunder shall be deemed to include, for purposes of this Section 2.8(d), any legal or other expenses
reasonably incurred by such indemnified party in connection with investigating, preparing to defend or defending against or appearing
as a third party witness in respect of, or otherwise incurred in connection with, any such loss, claim, damage, expense, liability,
action, investigation or proceeding. If indemnification is available under this Section 2.8, the indemnifying parties shall
indemnify each indemnified party to the full extent provided in Section 2.8(a) and Section 2.8(b) hereof without
regard to the relative fault of said indemnifying parties or indemnified party.

 

    	 	12	 

     

    

 

2.9          Reporting
Requirements; Rule 144. The Company shall use its commercially reasonable efforts to be and remain in compliance with the periodic
filing requirements imposed under the SEC’s rules and regulations, including the Exchange Act, and thereafter shall timely
file such information, documents and reports as the SEC may require or prescribe under Section 13 or 15(d) (whichever is applicable)
of the Exchange Act. If the Company is not required to file such reports during such period, it will, upon the request of any Holder,
make publicly available such necessary information for so long as necessary to permit sales pursuant to Rule 144 or Regulation
S under the Securities Act, and it will take such further action as any Holder may reasonably request, all to the extent required
from time to time to enable such Holder to sell Registrable Securities without Registration under the Securities Act within the
limitation of the exemptions provided by (a) Rule 144 or Regulation S under the Securities Act, as such Rules may be amended from
time to time, or (b) any rule or regulation hereafter adopted by the SEC.

 

2.10        Termination.
The Company shall have no obligations to register any Registrable Securities proposed to be sold by any Holder upon the earlier
of (i) the third anniversary of the Lockup Date and (ii) such time as there are no Registrable Securities.

 

		3.	Transfer 

 

3.1          Transfer
Restrictions.

 

(a)       Subject
to Section 3.1(c), the Investor shall not, and shall cause its Affiliates not to, directly or indirectly, transfer, sell,
hedge, assign, gift, pledge, encumber, hypothecate, mortgage, exchange or otherwise dispose, by operation of Law or otherwise (any
such occurrence, a “Transfer”), (i) any Purchased Shares prior to the date that is one (1) year following the
date of Closing (such date, the “Lockup Date”), or (ii) any Existing Shares prior to the date that is six (6)
months following the date of the Share Subscription Agreement (“Additional Lockup Date”), in each case, without
the prior written consent of the Company.

 

    	 	13	 

     

    

 

(b)       Subject
to Section 3.1(c), unless otherwise agreed by the Company in writing, the Investor shall not, and shall cause its Affiliates
not to, Transfer to any Company Competitor (i) any Purchased Shares within twelve (12) months after the Lockup Date, or (ii) any
Existing Shares within twelve (12) months after the Additional Lockup Date, in each case of (i) and (ii), other than any Transfer
through open market brokerage transaction where the identity of the purchaser is unknown.

 

(c)       Notwithstanding
the foregoing, the Investor may at any time Transfer its Lockup Shares to a Permitted Transferee; provided that prior to
any Transfer pursuant to this Section 3.1(c), such Permitted Transferee shall have agreed in writing to be bound by the
terms of this Agreement pursuant to documentation reasonably satisfactory to the Company; provided, further, that
no Transfer pursuant to this Section 3.1(c) shall relieve any transferor from any liability for damages incurred or suffered
by the Company as a result of any breach of this Agreement by such transferor.

 

3.2           No
Avoidance of Restrictions. The Parties hereto agree that the Transfer restrictions in this Agreement shall not be capable of
being avoided by the holding of Lockup Shares indirectly through a company or other entity that can itself be sold in order to
dispose of an interest in Lockup Shares free of such restrictions, or any trust, derivative contract or other economic arrangement
transferring the benefits of ownership of any Lockup Shares. The Investor undertakes that it shall not take any action intended
to avoid such restrictions in any manner. Any Transfer or other disposal of any shares (or other interest) resulting in any change
in the control of the Investor or of any Person having control over the Investor shall be treated as being a Transfer of the Lockup
Shares held by the Investor, and the provisions of this Agreement that apply in respect of the Transfer of Lockup Shares shall
thereupon apply in respect of the Lockup Shares so held. Any Transfer in violation of this Section 3.2 shall be null and
void ab initio and have no force or effect whatsoever.

 

		4.	Voting Agreement 

 

4.1          The
Investor hereby agrees that, until the Lockup Date, (A) without prejudice to the rights of the Investor set forth in clause (B),
the Investor shall not, and shall cause its Affiliates who hold any Company Securities not to, solicit, effect or seek to effect,
offer or propose (whether publicly or otherwise) to effect, or cause or participate in, or in any way knowingly assist or facilitate
any other person to effect or seek, offer or propose (whether publicly or otherwise) to effect or participate in, or make any public
statement with respect to, any action with respect to the Company or its Subsidiaries (as defined in the Share Subscription Agreement)
(including without limitation any merger, consolidation, business combination, tender or exchange offer involving the Company)
that is not recommended by the Board, and (B) at any meeting of the shareholders of the Company, however called, or at any adjournment
or postponement thereof (a “Company Shareholders’ Meeting”), or in any other circumstances upon which
a vote, consent or other approval (including by written consent) is sought by or from the shareholders of the Company: (i) the
Investor shall, and shall cause its Affiliates who hold any Company Securities to, appear at such Company Shareholders’ Meeting
or otherwise cause all Company Securities Beneficially Owned by the Investor or its Affiliates to be counted as present thereat
for the purpose of establishing a quorum and shall take all other necessary or desirable actions within their control (including,
without limitation, execution of written consents or resolutions in lieu of meetings); and (ii) with respect to any matter upon
which a vote, consent or other approval (including by written consent) is sought by or from the shareholders of the Company, the
Investor shall, and shall cause its Affiliates who hold any Company Securities to, vote and cause to be voted all Company Securities
Beneficially Owned by the Investor or its Affiliates in the manner recommended by the Board at any such Company Shareholders’
Meeting or under any such other circumstances upon which a vote, consent or other approval (including by written consent) is sought,
in the case of (B), (x) to the extent such Company Securities may be voted on such matter and (y) other than with respect to any
such matter (1) that relates to a transaction between the Company, on the one hand, and any Affiliate of the Company or any officer,
director, shareholder or member of the Company or any of its Affiliates, on the other hand, (2) that relates to the disposition
of a material portion of the assets or securities of the Company and its Subsidiaries (as defined in the Share Subscription Agreement),
taken as a whole, or (3) that constitutes a material violation of applicable Law by the Company.

 

    	 	14	 

     

    

 

		5.	Corporate Governance 

 

5.1           Investor
Nominee Director.

 

(a)       The
minimum number of directors on the Board shall be five and the maximum number shall be seven, of whom one director shall be designated
by the Investor (such nominee, or such other individual who may be designated by the Investor from time to time in accordance with
this Agreement, the “Investor Nominee”). On the date hereof, or if prior to the date hereof the Investor has
not provided notice to the Company of the Investor Nominee together with the Investor Nominee’s consent to serve as a director,
within five (5) Business Days after written notice by the Investor of its initial Investor Nominee and delivery of the applicable
consent form to the Company (which notice and delivery may be made solely via email), the Board shall appoint such Investor Nominee
to serve on the Board.

 

(b)       In
the event of the death, disability, retirement or resignation of the Investor Nominee or any change of designation of the Investor
Nominee by the Investor, the Investor shall have the exclusive right to designate another individual (the “Replacement
Nominee”) to fill such vacancy and serve on the Board, and the Company shall use all best efforts to ensure that the
Replacement Nominee is so appointed to the Board within five Business Days after designation of such Replacement Nominee in writing
by the Investor.

 

5.2          Termination
of Governance Rights. Notwithstanding anything in this Agreement to the contrary, on the date (i) the Initial Investor Ownership
Percentage is less than 75% and (ii) the Investor’s Aggregate Ownership Percentage is less than 15%, the Investor shall have
no further rights, and the Company shall have no further obligations, under Section 5.1 of this Agreement.

 

		6.	Issuance of New Securities 

 

 6.1           Consent Rights of Investor.

 

(a)       As
long as the Investor owns at least fifty percent (50%) of the Ordinary Shares it owns on the date of Closing (as proportionally
adjusted to give effect to any stock split, stock dividend, recapitalization or any similar transaction after the Closing), the
Company may not undertake to issue any New Securities (in a single transaction or a series of related transactions) without the
written consent of the Investor, not to be unreasonably withheld.

 

 

    	 	15	 

     

    

 

(b)       Provided
that such written consent of the Investor is required at such time that the Company proposes to undertake an issuance of New Securities,
it shall give to the Investor written notice of its intention to issue New Securities (the “Issuance Notice”),
describing the amount and type of New Securities, the price and the general terms upon which the Company proposes to issue such
New Securities in accordance with Section 7.4 of this Agreement. The Investor shall have ten (10) Business Days from the
date of receipt of any such Issuance Notice (the “Issuance Consent Period”) to withhold its consent in writing
to the Issuance of such New Securities for the price and upon the terms and conditions specified in the Issuance Notice by giving
written notice to the Company. If the Investor fails to so withhold its consent in writing within the Issuance Consent Period to
such proposed issuance of New Securities, then the Investor shall be deemed to have provided written consent to such issuance under
Section 6.1(a) of this Agreement.

 

		7.	Miscellaneous 

 

7.1          Governing
Law. This Agreement shall be governed by, and construed in accordance with, the Laws of the State of New York without regard
to its conflicts of law principles thereof.

 

7.2           Dispute
Resolution. Any dispute, controversy or claim arising out of or relating to this Agreement or its subject matter shall
be finally settled by arbitration. The place and seat of arbitration shall be Hong Kong, and the arbitration shall be
administered by the Hong Kong International Arbitration Centre (the “HKIAC”) in accordance with the HKIAC
Administered Arbitration Rules then in force (the “HKIAC Rules”). The number of arbitrators shall be three
(3). Each Party shall appoint one arbitrator and the third arbitrator, who shall serve as chairperson of the arbitral
tribunal, shall be selected by the mutual agreement of the first two arbitrators. Any arbitrator that is not so appointed
shall instead be appointed in accordance with the HKIAC Rules. The language to be used in the arbitration proceedings shall
be English. The award of the arbitral tribunal shall be final, conclusive and binding upon the Parties. Judgment upon any
award may be entered and enforced in any court having jurisdiction over a Party or any of its assets. For the purpose of the
enforcement of an award, the Parties irrevocably and unconditionally submit to the jurisdiction of any competent court and
waive any defenses to such enforcement, including any defenses based on lack of personal jurisdiction or inconvenient
forum.

 

7.3          Counterparts.
This Agreement may be executed and delivered (including by electronic transmission in PDF format or by facsimile transmission)
in one or more counterparts, and by the Parties in separate counterparts, each of which when executed shall be deemed to be an
original but all of which taken together shall constitute one and the same agreement.

 

7.4           Notices.
Any notice required or permitted pursuant to this Agreement shall be given in writing and shall be given either personally or by
sending it by next-day or second-day courier service, fax, electronic mail or similar means to such Party. Where a notice is sent
by next-day or second-day courier service, service of the notice shall be deemed to be effected by properly addressing, pre-paying
and sending by next-day or second-day service through an internationally-recognized courier a letter containing the notice, with
a confirmation of delivery, and to have been effected at the expiration of two days after the letter containing the same is sent
as aforesaid. Where a notice is sent by fax or electronic mail, service of the notice shall be deemed to be effected by properly
addressing, and sending such notice through a transmitting organization, with a written confirmation of delivery, and to have been
effected on the day the same is sent as aforesaid.

 

    	 	16	 

     

    

 

7.5          Successors
and Assigns. This Agreement shall be binding upon and inure solely to the benefit of each Party, and nothing in this Agreement,
express or implied, is intended to confer upon any other person any right, benefit or remedy of any nature whatsoever under or
by reason of this Agreement. Neither this Agreement nor any of the rights or obligations of any Party may be assigned by any Party
without the prior written consent of the other Party, except that (a) the Investor may assign this Agreement and the rights or
obligations of the Investor hereunder to any of its Affiliates and (b) the registration rights of the Investor with respect to
any Registrable Securities may be transferred to a Permitted Transferee of the Investor (i) to which Registrable Securities have
been transferred and (ii) who executes and delivers to the Company a written instrument in form and substance reasonably satisfactory
to the Company agreeing to be bound by and entitled to the benefits of, the terms of this Agreement, and any purported assignment
in breach hereof by the Investor shall be void. Each Party hereto who transfers Registrable Securities to a Permitted Transferee
shall cause such Permitted Transferee to execute and deliver to the Company a written instrument in form and substance reasonably
satisfactory to the Company agreeing to be bound by and entitled to the benefits of, the terms of this Agreement.

 

7.6          Headings
and Titles. Headings and titles used in this Agreement are used for convenience only and are not to be considered in construing
or interpreting this Agreement.

 

7.7          Entire
Agreement; Amendments and Waivers. This Agreement constitutes the full and entire understanding and agreement among the Parties
with regard to the subjects hereof and thereof, and supersedes all other agreements between or among any of the Parties with respect
to the subject matter hereof. Any term of this Agreement may be amended and the observance of any term of this Agreement may be
waived (either generally or in a particular instance and either retroactively or prospectively) only with the written consent of
both Parties.

 

7.8           Severability.
If a provision of this Agreement is held to be unenforceable under applicable Laws, such provision shall be excluded from this
Agreement and the remainder of the Agreement shall be interpreted as if such provision were so excluded and shall be enforceable
in accordance with its terms.

 

7.9           Further
Assurances. The Parties agree to execute such further instruments and to take such further action as may be reasonably necessary
to carry out the intent of this Agreement.

 

7.10         Rights
Cumulative. Each and all of the various rights, powers and remedies of a Party hereto will be considered to be cumulative with
and in addition to any other rights, powers and remedies which such Party may have at law or in equity in the event of the breach
of any of the terms of this Agreement. The exercise or partial exercise of any right, power or remedy will neither constitute the
exclusive election thereof nor the waiver of any other right, power or remedy available to such Party.

 

    	 	17	 

     

    

 

7.11         No
Waiver. Failure to insist upon strict compliance with any of the terms, covenants, or conditions hereof will not be deemed
a waiver of such term, covenant, or condition, nor will any waiver or relinquishment of, or failure to insist upon strict compliance
with, any right, power or remedy power hereunder at any one or more times be deemed a waiver or relinquishment of such right, power
or remedy at any other time or times.

 

7.12         No
Presumption. The Parties acknowledge that any applicable Law that would require interpretation of any claimed ambiguities in
this Agreement against the Party that drafted it has no application and is expressly waived. If any claim is made by a Party relating
to any conflict, omission or ambiguity in the provisions of this Agreement, no presumption or burden of proof or persuasion will
be implied because this Agreement was prepared by or at the request of any Party or its counsel.

 

[Signature page follows]

 

    	 	18	 

     

    

 

IN WITNESS WHEREOF, the Parties hereto have
executed this Agreement as of the date first written above.

 

	 	LONG HAN INVESTMENT
	 	MANAGEMENT CO., LTD.
	 	(隆瀚投资管理有限公司)
	 	 	 	 
	 	By:	 
	 	 	Name:	Shuang Cheng Zhou
	 	 	Title:	Chief Executive Officer

 

[Signature Page to Investor Rights Agreement]

 

     

     

    

 

IN WITNESS WHEREOF, the Parties hereto have
executed this Agreement as of the date first written above.

 

	 	ORIGIN AGRITECH LIMITED
	 	 	 	 
	 	By:	 
	 	 	Name:	Zheng James Chen
	 	 	Title:	Chief Executive Officer

 

[Signature Page to Investor Rights Agreement]

 

     

     

    

 

Schedule I

Company Competitors

 

Company Names

 

		1.	Yuan Long Ping High-Tech Agriculture Co., Ltd. (referred to as “Long Ping High-Tech”)
(隆平高科)

 

		2.	Shandong Denghai Seeds Co., Ltd (山东登海种业股份有限公司)

 

		3.	Beijing Golden Seeds Science & Technology Co., Ltd (北京金色农华种业科技有限公司)

 

		4.	Liaoning East-Asia Seeds Co., Ltd (辽宁东亚种业)

 

		5.	China National Seed Group Co., Ltd (中国种子集团有限公司)

 

		6.	Beijing Lantron Seed Corporation (北京联创种业股份有限公司)

 

		7.	Beijing Doneed Seed Co. Ltd (北京德农种业有限公司)

 

		8.	Henan Jin Yuan Seed Corporation (河南金苑种业股份有限公司)

 

		9.	SinoFarm Genetics & Seeds (Group) Co., Ltd (中地种业
                                                           (集团)
                                                           有限公司)

 

		10.	Henan Qiule Seed Industry Science & Technology Ltd (河南秋乐种业科技股份有限公司)

 

		11.	Henan Dr. Jin Seed Corporation (河南金博士种业股份有限公司)

 

		12.	Dupont Pioneer (杜邦先锋公司)

 

		13.	Beijing Chemical Technology Seeds Co., Ltd (北京化工种业有限公司)

 

		14.	Henan Huafeng Seeds Science & Technology Co., Ltd (河南滑丰种业科技有限公司)

 

		15.	Join Hope Seeds Co., Ltd (新疆九禾种业 (已更名为九圣禾种业股份有限公司)

 

		16.	Hebei Xuntian Agriculture Co. Ltd. (河北巡天农业科技有限公司)

 

		17.	Shouguang Hongxiang Seed Co. Ltd. (寿光宏翔种业)

 

		18.	Heilongjiang Kenfeng Seed Co. Ltd. (黑龙江垦丰种业有限公司)

 

		19.	Beijing Shunxin Seed Co. Ltd. (北京顺鑫种业科技有限公司)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00296-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00296-of-00352.parquet"}]]